https://www.pharmaceutical-business-review.com/news/european-commission-grants-marketing-authorization-for-omeros-omidria-040815-4638802/ 2015-08-04T10:08:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-makes-unsolicited-306bn-bid-to-acquire-baxter-spin-off-baxalta-050815-4639033/ 2015-08-05T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/im-healthscience-receives-no-objections-from-health-canadas-nnhpd-for-efficacy-supplement-on-ibgard-050815-4639334/ 2015-08-05T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/orexo-provides-zubsolv-market-access-update-on-agreement-with-cvs-caremark-050815-4639347/ 2015-08-05T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-pars-anda-for-ethacrynate-sodium-for-injection-usp-050815-4639392/ 2015-08-05T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-to-end-contract-with-ucsd-for-a4-alzheimers-trial-050815-4639477/ 2015-08-05T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-doses-first-patient-in-phase-ii-trial-of-anti-il-6r-nanobody-alx-0061-to-treat-sle-050815-4639496/ 2015-08-05T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-gets-european-commission-approval-for-17bn-acquisition-of-hospira-050815-4639528/ 2015-08-05T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-status-for-immunomedics-veltuzumab-to-treat-immune-thrombocytopenia-050815-4639558/ 2015-08-05T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofis-insulin-toujeo-now-available-in-uk-to-treat-adults-with-diabetes-050815-4639885/ 2015-08-05T09:30:00+00:00 https://www.pharmaceutical-business-review.com/news/minerva-biotechnologies-gets-worldwide-license-to-ips-technology-050815-4639887/ 2015-08-05T09:35:00+00:00 https://www.pharmaceutical-business-review.com/news/flexion-enters-into-strategic-manufacturing-supply-deal-with-patheon-for-fx006-050815-4639890/ 2015-08-05T09:38:00+00:00 https://www.pharmaceutical-business-review.com/news/allena-begins-phase-iib-trial-of-alln-177-to-treat-secondary-hyperoxaluria-050815-4639879/ 2015-08-06T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-nexium-delayed-release-capsules-in-us-to-treat-gerd-060815-4640171/ 2015-08-06T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-mirati-to-conduct-phase-iii-immuno-oncology-combination-trial-to-treat-lung-cancer-060815-4640122/ 2015-08-06T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/aerie-enters-into-research-collaboration-with-graybug-for-new-delivery-technologies-060815-4640608/ 2015-08-06T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-status-for-marinas-ceq508-to-treat-familial-adenomatous-polyposis-060815-4640644/ 2015-08-06T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/ironwood-allergan-partner-to-co-promote-viberzi-in-us-to-treat-ibs-with-diarrhea-060815-4640753/ 2015-08-06T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/la-jolla-signs-two-exclusive-worldwide-license-agreements-for-gentamicin-derivatives-060815-4640781/ 2015-08-06T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/marathon-to-begin-nda-process-for-deflazacort-to-treat-patients-with-duchenne-muscular-dystrophy-060815-4641196/ 2015-08-06T09:25:00+00:00 https://www.pharmaceutical-business-review.com/news/hsrx-group-acquires-ready-for-market-otc-drugs-060815-4641198/ 2015-08-06T09:28:00+00:00 https://www.pharmaceutical-business-review.com/news/arch-biopartners-gets-us-patent-for-brain-tumor-targeting-peptides-060815-4641201/ 2015-08-06T09:32:00+00:00 https://www.pharmaceutical-business-review.com/news/hetero-launches-biosimilar-rituximab-in-india-060815-4641205/ 2015-08-06T09:35:00+00:00 https://www.pharmaceutical-business-review.com/news/cytodyn-initiates-first-clinical-site-for-phase-iii-trial-of-pro-140-in-hiv-positive-patients-060815-4640568/ 2015-08-06T09:39:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaxis-synairgen-to-develop-loxl2-inhibitor-for-pulmonary-fibrosis-060815-4641206/ 2015-08-06T09:41:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-cma-accuses-pfizer-and-flynn-of-inflating-anti-epilepsy-drug-price-070815-4641452/ 2015-08-07T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-enters-510m-heptares-deal-to-develop-new-immuno-oncology-treatments-070815-4641562/ 2015-08-07T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-pharma-gets-fda-fast-track-and-ema-orphan-status-for-intravenous-cannabidiol-to-treat-nhie-070815-4641888/ 2015-08-07T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-theravances-breo-ellipta-gets-canadian-approval-to-treat-asthma-in-adults-070815-4641919/ 2015-08-07T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-gets-fda-fast-track-status-for-td-8954-to-treat-gastrointestinal-motility-disorders-070815-4641861/ 2015-08-07T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/ucsf-begins-clinical-trial-of-halozymes-pegph20-to-treat-pancreatic-cancer-patients-070815-4642010/ 2015-08-07T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/lsk-biopharma-hci-enter-license-agreement-for-hci-1401-to-treat-b-cell-malignancies-070815-4642041/ 2015-08-07T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/mabvax-and-the-rockefeller-university-enter-into-collaborative-research-agreement-070815-4642485/ 2015-08-07T09:33:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-accepts-knight-therapeutics-new-drug-submission-for-atryn-070815-4642488/ 2015-08-07T09:37:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-orphan-drug-status-to-dicernas-dcr-ph1-to-treta-primary-hyperoxaluria-type-1-070815-4642497/ 2015-08-07T09:56:00+00:00 https://www.pharmaceutical-business-review.com/news/celsion-reports-updated-results-from-heat-study-of-thermodox-to-treat-primary-liver-cancer-070815-4642498/ 2015-08-07T10:01:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-evotec-to-develop-stem-cell-based-treatments-for-diabetes-100815-4642728/ 2015-08-10T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/uks-chiltern-agrees-to-buy-theorem-clinical-research-100815-4642980/ 2015-08-10T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/newcastle-university-gets-gbp5m-grant-to-develop-new-cancer-drugs-100815-4643097/ 2015-08-10T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-recommends-daiichi-sankyos-lixiana-to-prevent-stroke-and-systemic-embolism-in-af-patients-100815-4643151/ 2015-08-10T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-launches-lung-cancer-drug-nivolumab-in-uk-100815-4643190/ 2015-08-10T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/valor-gets-fda-approval-for-ind-application-to-start-phase-i-trial-of-ign002-to-treat-nhl-100815-4643398/ 2015-08-10T09:16:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-expands-phase-iii-trial-in-europe-using-xilonix-to-treat-metastatic-colorectal-cancer-100815-4643369/ 2015-08-10T09:17:00+00:00 https://www.pharmaceutical-business-review.com/news/icardiac-acquires-nspire-healths-clinical-trials-division-100815-4643531/ 2015-08-10T10:18:00+00:00 https://www.pharmaceutical-business-review.com/news/hydropothecary-gets-health-canada-approval-to-produce-cannabis-oil-from-medical-marijuana-100815-4643533/ 2015-08-10T10:21:00+00:00 https://www.pharmaceutical-business-review.com/news/ember-raises-up-to-6m-establishes-commercial-partnership-with-knight-therapeutics-100815-4643534/ 2015-08-10T10:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-to-review-collegiums-xtampza-er-for-chronic-pain-100815-4643537/ 2015-08-10T10:30:00+00:00 https://www.pharmaceutical-business-review.com/news/symbiomix-reports-positive-trial-results-for-sym-1219-for-bacterial-vaginosis-100815-4643540/ 2015-08-10T10:34:00+00:00 https://www.pharmaceutical-business-review.com/news/somalogic-otsuka-extend-research-collaboration-for-therapeutic-somamer-development-110815-4644621/ 2015-08-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-doses-first-patient-in-phase-ii-dose-ranging-optic-trial-of-iclusig-110815-4644630/ 2015-08-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/upsher-smith-gets-fda-approval-for-generic-namenda-tablets-110815-4644633/ 2015-08-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aduro-completes-patient-enrollment-in-phase-ib-trial-of-crs-207-to-treat-mesothelioma-110815-4644636/ 2015-08-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/turing-acquires-us-marketing-rights-to-daraprim-from-impax-laboratories-110815-4644646/ 2015-08-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/immune-design-merck-to-evaluate-two-immunotherapies-with-keytruda-to-treat-nhl-and-melanoma-110815-4644670/ 2015-08-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medimmune-inovio-enters-into-strategic-cancer-vaccine-collaboration-110815-4643717/ 2015-08-11T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/bioclin-begins-phase-ii-trial-of-b-701-to-treat-urothelial-cell-carcinoma-110815-4644214/ 2015-08-11T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/vitae-starts-phase-i-multiple-ascending-dose-trial-of-vtp-43742-to-treat-autoimmune-disorders-110815-4644232/ 2015-08-11T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fresenius-kabi-launches-cisatracurium-besylate-injection-in-us-110815-4644263/ 2015-08-11T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/taros-keveyis-get-fda-approval-to-treat-primary-hyperkalemic-and-hypokalemic-periodic-paralysis-110815-4644306/ 2015-08-11T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/gliknik-licensee-pfizer-gets-fda-orphan-drug-status-for-gl-2045-to-treat-rare-neurological-disorder-110815-4644334/ 2015-08-11T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-closes-north-carolina-plant-after-legionella-bacteria-found-in-cooling-tower-120815-4644845/ 2015-08-12T02:14:00+00:00 https://www.pharmaceutical-business-review.com/news/alvogen-launches-generic-cancer-drug-velcade-in-bulgaria-120815-4645240/ 2015-08-12T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-confirms-patent-challenge-for-generic-noxafil-120815-4645282/ 2015-08-12T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-la-jollas-ind-for-ljpc-401-to-treat-iron-overload-120815-4645331/ 2015-08-12T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/doctors-best-introduces-menostrong-with-genivida-120815-4645236/ 2015-08-12T06:00:00+00:00 https://www.pharmaceutical-business-review.com/news/dksh-signs-agreement-with-actelion-to-drive-growth-in-asia-120815-4645377/ 2015-08-12T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/mannatech-to-release-aloe-based-manapol-powder-on-19-august-120815-4645241/ 2015-08-12T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-expands-deal-with-emerge-to-commercialize-alferon-in-australia-and-new-zealand-120815-4645447/ 2015-08-12T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-evotec-and-apeiron-to-develop-new-small-molecule-immuno-oncology-treatments-120815-4645727/ 2015-08-12T09:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-snda-for-review-of-takeda-and-lundbecks-brintellix-in-mdd-patients-120815-4645644/ 2015-08-12T09:26:00+00:00 https://www.pharmaceutical-business-review.com/news/poseida-to-use-janssen-centyrin-technology-to-develop-car-therapies-120815-4645730/ 2015-08-12T09:30:00+00:00 https://www.pharmaceutical-business-review.com/news/g1-therapeutics-begins-two-phase-ibiia-trials-of-cdk46-inhibitor-g1t28-in-small-cell-lung-cancer-120815-4645732/ 2015-08-12T09:34:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-tevas-nda-for-sd-809-to-treat-huntington-disease-130815-4646306/ 2015-08-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-to-use-circuit-optogenetics-technology-to-develop-new-obesity-drugs-130815-4645938/ 2015-08-13T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/proteon-begins-second-phase-iii-trial-of-investigational-drug-vonapanitase-130815-4646275/ 2015-08-13T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-reports-positive-phase-ii-trial-results-of-leukemia-drug-venetoclax-130815-4646330/ 2015-08-13T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/neuropore-begins-phase-1-clinical-trials-with-npt200-11-to-treat-parkinsons-disease-130815-4646354/ 2015-08-13T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/sinoveda-signs-commercialization-agreement-with-exzell-pharma-for-effecti-cal-130815-4646385/ 2015-08-13T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/cmc-biologics-path-malaria-vaccine-initiative-to-develop-new-monoclonal-antibodies-130815-4646687/ 2015-08-13T09:19:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocellular-reaches-deal-with-fda-on-spa-for-ict-107-phase-iii-registrational-trial-in-gllioblastoma-140815-4647462/ 2015-08-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/proteon-reports-top-line-results-from-phase-i-trial-vonapanitase-in-patients-with-symptomatic-pad-140815-4647464/ 2015-08-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hua-medicines-gka-diabetes-drug-demonstrates-high-efficacy-in-4-week-phase-ic-trial-140815-4647469/ 2015-08-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fsc-pediatrics-launches-karbinal-er-to-treat-seasonal-and-perennial-allergic-rhinitis-140815-4647470/ 2015-08-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-md-anderson-enter-immuno-oncology-research-collaboration-in-solid-tumors-140815-4646854/ 2015-08-14T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-to-develop-and-commercialize-alligators-immuno-oncology-agent-adc-1013-140815-4646897/ 2015-08-14T03:32:00+00:00 https://www.pharmaceutical-business-review.com/news/neurocrine-completes-enrollment-in-phase-iii-tardive-dyskinesia-trial-of-nbi-98854-140815-4647098/ 2015-08-14T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/sifi-to-distribute-alimeras-dme-treatment-iluvien-in-italy-san-marino-and-vatican-city-140815-4647147/ 2015-08-14T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-biogens-plegridy-to-treat-relapsing-remitting-multiple-sclerosis-in-adults-140815-4647178/ 2015-08-14T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/catabasis-reports-positive-phase-i-data-for-hypercholesterolemia-drug-candidate-cat-2054-140815-4647206/ 2015-08-14T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/new-wuxi-life-science-to-acquire-wuxi-pharmatech-for-33bn-4647654/ 2015-08-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/imprimis-to-expand-proprietary-ophthalmic-formulations-into-canada-170815-4647865/ 2015-08-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genentechs-pivotal-phase-ii-study-of-atezolizumab-meets-end-points-170815-4648643/ 2015-08-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-ties-up-with-novo-nordisk-for-duobody-technology-170815-4647989/ 2015-08-17T05:23:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/sydney-researchers-advance-drug-discovery-for-melanoma-treatment-170815-4647846/ 2015-08-17T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-baxter-and-water-streets-cefazolin-injection-2gm-for-preoperative-prophylaxis-170815-4648101/ 2015-08-17T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/aveo-novartis-enter-exclusive-worldwide-license-agreement-for-av-380-and-related-antibodies-170815-4648271/ 2015-08-17T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-marketing-authorisation-to-unituxin-dinutuximab-for-paediatric-high-risk-neuroblastoma-170815-4648348/ 2015-08-17T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/veloxis-envarsus-xr-gets-orphan-drug-status-for-kidney-transplant-rejection-prophylaxis-170815-4648497/ 2015-08-17T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/hifibio-sas-achieves-milestone-in-antibody-research-collaboration-with-pfizer-140815-4647471/ 2015-08-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfenex-wins-1435m-barda-contract-to-develop-new-anthrax-vaccine-180815-4648711/ 2015-08-18T01:41:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-completes-takeover-of-cord-blood-registry-for-700m-180815-4648810/ 2015-08-18T03:53:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-begins-phase-iib-trial-of-new-aml-consolidation-treatment-bl-8040-180815-4649120/ 2015-08-18T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-insites-nda-filing-for-pain-drug-bromsite-180815-4649147/ 2015-08-18T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/insyss-nda-for-dronabinol-oral-solution-accepted-for-filing-by-us-fda-180815-4649175/ 2015-08-18T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/chiasmas-nda-for-octreotide-capsules-in-acromegaly-gets-fda-acceptance-for-filing-180815-4649324/ 2015-08-18T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-completes-enrollment-for-xilonix-phase-iii-registration-study-in-europe-180815-4649660/ 2015-08-18T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-announces-results-from-b-yond-extension-study-of-alprolix-for-hemophilia-b-180815-4649667/ 2015-08-18T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/epiduo-forte-gel-0325-prescription-treatment-now-available-for-acne-patients-180815-4649670/ 2015-08-18T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/relmada-gets-health-canada-clearance-to-begin-mad-study-with-nmda-receptor-antagonist-180815-4649597/ 2015-08-18T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-alexions-strensiq-to-treat-patients-with-hypophosphatasia-180815-4649735/ 2015-08-18T09:20:00+00:00 https://www.pharmaceutical-business-review.com/news/federal-judge-approves-consent-decree-with-iowa-select-herbs-180815-4649736/ 2015-08-18T09:24:00+00:00 https://www.pharmaceutical-business-review.com/news/delmar-gets-additional-non-dilutive-funding-from-nrc-irap-to-support-expanded-research-program-with-val-083-180815-4649738/ 2015-08-18T09:28:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-extends-strategic-alliance-with-armada-for-alferon-n-injection-180815-4649743/ 2015-08-18T09:32:00+00:00 https://www.pharmaceutical-business-review.com/news/r-pharm-acquires-ixempra-from-bristol-myers-launches-us-commercial-operations-180815-4649744/ 2015-08-18T09:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-sprouts-addyi-pill-for-hsdd-in-women-4650072/ 2015-08-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-recalls-temodar-and-temozolomide-bottles-with-cracked-caps-190815-4650156/ 2015-08-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-claims-to-be-first-to-file-patent-challenge-over-zytiga-190815-4650922/ 2015-08-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/botanic-choice-launches-three-new-nutritional-supplements-190815-4651312/ 2015-08-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-partners-with-academia-to-support-cancer-patient-advocacy-organizations-190815-4650398/ 2015-08-19T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-pharmaceuticals-buys-lg-sciences-brand-of-sports-nutrition-products-190815-4650469/ 2015-08-19T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/aspirin-reduces-obesity-cancer-risk-190815-4650491/ 2015-08-19T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/sobi-menarini-announce-approval-for-kineret-in-juvenile-idiopathic-arthritis-in-australia-190815-4650911/ 2015-08-19T08:39:00+00:00 https://www.pharmaceutical-business-review.com/news/oculus-innovative-sciences-launches-alevicyn-sg-antipruritic-spray-gel-for-atopic-dermatitis-190815-4650917/ 2015-08-19T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-nears-1bn-deal-with-sprout-for-libido-drug-addyi-200815-4651210/ 2015-08-20T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-rare-pediatric-disease-designation-for-biomarins-drisapersen-to-treat-dmd-200815-4651641/ 2015-08-20T05:22:00+00:00 https://www.pharmaceutical-business-review.com/news/cempras-solithromycin-gets-fda-fast-track-status-to-treat-cabp-200815-4651754/ 2015-08-20T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/madison-begins-dosing-in-prostate-cancer-trial-of-mvi-816-and-pembrolizumab-combination-200815-4651810/ 2015-08-20T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/corbus-gets-fda-fast-track-status-for-resunab-to-treat-systemic-sclerosis-200815-4651843/ 2015-08-20T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/engeneic-begins-phase-i-tailored-edv-clinical-trial-in-solid-tumors-200815-4652168/ 2015-08-20T09:10:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-qidp-designation-to-vicals-antifungal-product-candidate-vl-2397-200815-4652172/ 2015-08-20T09:13:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-pfizers-maa-for-breast-cancer-combination-treatment-210815-4652364/ 2015-08-21T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-odomzo-gets-approval-in-europe-to-treat-locally-advanced-basal-cell-carcinoma-210815-4652808/ 2015-08-21T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-and-janus-partner-to-develop-tlr-inhibitor-for-autoimmune-diseases-210815-4652815/ 2015-08-21T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-medimmune-begin-phase-iii-trial-of-combination-drug-to-treat-hpv-associated-cancers-210815-4652844/ 2015-08-21T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/sta-to-market-and-distribute-pharmamars-cancer-drug-aplidin-in-australia-and-new-zealand-210815-4652949/ 2015-08-21T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-allergans-botox-resubmission-to-treat-lower-limb-spasticity-in-adults-210815-4652989/ 2015-08-21T07:02:00+00:00 https://www.pharmaceutical-business-review.com/news/biota-begins-phase-i-sad-trial-of-direct-acting-antiviral-bta585-210815-4653113/ 2015-08-21T08:26:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-submits-extended-maa-for-paliperidone-palmitate-to-ema-for-schizophrenia-treatment-240815-4653508/ 2015-08-24T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-buys-remaining-rights-to-gsks-cancer-and-ms-drug-ofatumumab-for-about-1bn-240815-4653581/ 2015-08-24T03:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-rare-pediatric-disease-designation-for-sareptas-eteplirsen-to-treat-dmd-240815-4653825/ 2015-08-24T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/seres-secures-fda-orphan-drug-status-for-ser-109-to-prevent-recurrent-cdi-in-adults-240815-4653875/ 2015-08-24T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-takedas-maa-for-ixazomib-to-treat-relapsedrefractory-multiple-myeloma-240815-4653907/ 2015-08-24T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectar-introduces-pdc-platform-for-targeted-delivery-of-chemotherapeutics-240815-4653935/ 2015-08-24T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/mtg-biotherapeutics-gets-fda-orphan-drug-status-for-mtg-201-to-treat-malignant-mesothelioma-240815-4653978/ 2015-08-24T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-reports-positive-topline-results-of-two-phase-iii-trials-of-trumenba-240815-4654342/ 2015-08-24T10:39:00+00:00 https://www.pharmaceutical-business-review.com/news/vital-therapies-phase-iii-trial-of-elad-system-in-patients-with-aild-failed-to-meet-primary-endpoint-240815-4654344/ 2015-08-24T10:43:00+00:00 https://www.pharmaceutical-business-review.com/news/hedgepath-launches-clinical-trial-for-proposed-cancer-treatment-240815-4654346/ 2015-08-24T10:47:00+00:00 https://www.pharmaceutical-business-review.com/news/eas-consulting-announces-new-senior-advisor-for-otc-drugs-and-labeling-services-240815-4654347/ 2015-08-24T10:51:00+00:00 https://www.pharmaceutical-business-review.com/news/drugdev-centralizes-new-saas-solutions-development-for-clinical-research-240815-4654348/ 2015-08-24T10:58:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-peregrine-partner-on-immuno-oncology-combination-trial-to-treat-solid-tumors-250815-4654435/ 2015-08-25T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/retrosenses-rst-001-gets-fda-nod-to-start-first-in-human-clinical-trials-250815-4654799/ 2015-08-25T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-to-acquire-worldwide-rights-of-biomarins-cancer-drug-talazoparib-250815-4654860/ 2015-08-25T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/ironshore-begins-second-phase-iii-trial-of-hld-200-in-pediatric-adhd-patients-250815-4654830/ 2015-08-25T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-expands-use-of-novartis-promacta-to-include-treatment-for-chronic-itp-250815-4654914/ 2015-08-25T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/hsrx-nears-completion-of-otc-acne-treatment-trial-of-hsrx-2121-250815-4654967/ 2015-08-25T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-ind-application-of-biohavens-lead-drug-candidate-bhv-0223-250815-4655071/ 2015-08-25T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-recalls-specific-lots-of-refresh-lacri-lube-refresh-pm-35g-fml-01-and-blephamide-in-us-250815-4655441/ 2015-08-25T09:41:00+00:00 https://www.pharmaceutical-business-review.com/news/accutest-expands-into-latin-american-countries-to-support-drug-development-250815-4655444/ 2015-08-25T09:45:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-reports-positive-phase-iii-trial-results-for-fycompa-250815-4655445/ 2015-08-25T09:48:00+00:00 https://www.pharmaceutical-business-review.com/news/culturelle-debuts-only-triple-action-immune-boosting-supplement-to-include-probiotics-250815-4655446/ 2015-08-25T09:52:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-submits-nda-for-new-intravenous-calcimimetic-etelcalcetide-to-treat-shpt-in-ckd-patients-260815-4655583/ 2015-08-26T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/oncodrone-gets-eur25m-eurostars-grant-to-develop-prostate-cancer-drug-ocd155-260815-4656032/ 2015-08-26T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-begins-enrollment-in-phase-iiiii-trial-of-rviia-fp-to-treat-hemophilia-a-or-b-260815-4656089/ 2015-08-26T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/arbutus-begins-dosing-in-phase-iia-expansion-group-trial-of-tkm-plk1-to-treat-hcc-260815-4656134/ 2015-08-26T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-piperacillin-and-tazobactam-for-injection-in-us-260815-4656167/ 2015-08-26T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-to-secure-improved-cinryze-manufacturing-flexibility-and-capacity-260815-4656195/ 2015-08-26T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/clementia-enrols-children-in-ongoing-phase-ii-trial-of-palovarotene-to-treat-fop-260815-4656238/ 2015-08-26T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/santen-gets-approval-of-tapros-in-china-to-treat-open-angle-glaucoma-and-ocular-hypertension-260815-4656586/ 2015-08-26T09:21:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-gets-marketing-authorization-for-respreeza-in-europe-260815-4656587/ 2015-08-26T09:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-gets-orphan-drug-designation-for-tocagens-toca-511-toca-fc-to-treat-glioblastoma-260815-4656591/ 2015-08-26T09:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-ema-accept-regulatory-applications-for-boehringers-giotrifgilotrif-to-treat-advanced-squamous-cell-carcinoma-of-lung-260815-4656597/ 2015-08-26T09:38:00+00:00 https://www.pharmaceutical-business-review.com/news/corium-begins-phase-i-trial-of-corplex-donepezil-transdermal-system-to-treat-alzheimers-disease-260815-4656600/ 2015-08-26T09:46:00+00:00 https://www.pharmaceutical-business-review.com/news/syndax-genentech-enter-clinical-trial-collaboration-in-cancer-immunotherapy-270815-4657838/ 2015-08-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/immatics-anderson-launch-immatics-us-to-develop-multiple-t-cell-and-tcr-based-adoptive-cellular-therapies-270815-4657857/ 2015-08-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/oncolytics-completes-enrollment-in-randomized-phase-ii-nsclc-trial-270815-4657863/ 2015-08-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nejm-publishes-gsks-phase-iiibiv-study-of-ambrisentan-and-tadalafil-to-treat-pah-patients-270815-4657872/ 2015-08-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/enumeral-umass-medical-school-enter-into-research-study-agreement-270815-4657886/ 2015-08-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-to-invest-2bn-in-new-manufacturing-facilities-in-us-and-denmark-270815-4656876/ 2015-08-27T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/audentes-gets-orphan-status-for-at001-to-treat-xlmtm-in-us-and-europe-270815-4657269/ 2015-08-27T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/alvogen-to-buy-four-pharmaceutical-products-from-pfizer-for-us-market-270815-4657295/ 2015-08-27T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-to-expand-rights-related-to-nanotherapeutics-vero-cell-technology-platform-270815-4657318/ 2015-08-27T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/corium-gets-us-patent-for-microcor-transdermal-system-270815-4657341/ 2015-08-27T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/recipharm-to-manufacture-redhills-rhb-105-to-treat-h-pylori-infection-270815-4657378/ 2015-08-27T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/symic-biomedical-gets-15m-nih-phase-ii-sbir-grant-to-develop-proteoglycan-mimetic-therapeutics-270815-4657881/ 2015-08-28T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-strengthens-ii-portfolio-with-72bn-receptos-acquisition-280815-4657971/ 2015-08-28T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-boehringer-and-lillys-synjardy-to-treat-type-2-diabetes-in-adults-280515-4658044/ 2015-08-28T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/biohaven-begins-dosing-in-phase-i-trial-with-lead-drug-candidate-bhv-0223-280815-4658210/ 2015-08-28T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/threshold-begins-phase-ii-trial-tarloxotinib-to-treat-head-and-neck-or-skin-cancers-280815-4658231/ 2015-08-28T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/allied-bristol-life-sciences-licenses-yale-universitys-platform-technology-and-lead-molecules-280815-4658263/ 2015-08-28T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/biolab-to-open-new-rd-centre-in-greater-toronto-area-280815-4658288/ 2015-08-28T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/sucampo-launches-tender-to-buy-r-tech-ueno-for-278m-280815-4658314/ 2015-08-28T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/minerva-licenses-sendai-virus-technology-for-stem-cell-generation-280815-4658427/ 2015-08-28T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-gets-additional-niaid-funding-to-advance-development-of-orbeshield-in-gi-ars-280815-4658440/ 2015-08-28T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/symbiomix-completes-enrollment-in-second-pivotal-trial-of-sym-1219-for-bacterial-vaginosis-280815-4658448/ 2015-08-28T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-pharmatechs-sta-subsidiary-gets-first-approval-from-japanese-regulatory-authorities-280815-4658462/ 2015-08-28T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-qimr-to-discover-new-immuno-oncology-antibodies-310815-4658743/ 2015-08-31T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/micurx-reports-positive-phase-ii-trial-results-for-mrx-i-to-treat-mrsa-and-vre-310815-4659110/ 2015-08-31T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/telesta-secures-bla-filing-notification-and-priority-review-designation-from-fda-for-mcna-310815-4659220/ 2015-08-31T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-acquires-glaxosmithklines-otc-drugs-portfolio-for-200m-310815-4658974/ 2015-08-31T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-amgens-repatha-injection-to-treat-certain-patients-with-high-cholesterol-310815-4659210/ 2015-08-31T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-new-indication-for-sunovions-aptiom-as-monotherapy-for-partial-onset-seizures-310815-4659017/ 2015-08-31T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/esc-launches-new-concept-for-driving-innovation-in-cardiovascular-research-with-support-from-boehringer-310815-4659248/ 2015-08-31T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/celyad-enter-into-license-agreement-with-medisun-for-c-cure-in-greater-china-310815-4659243/ 2015-08-31T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-announces-first-regulatory-approval-of-cobimetinib-in-switzerland-4659274/ 2015-08-31T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-biopharma-gets-notice-of-allowance-for-new-israeli-patent-covering-rhb-104-to-treat-crohns-disease-310815-4659284/ 2015-08-31T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/qb3953-signs-collaboration-agreement-with-gsk-to-identify-early-stage-drug-discovery-opportunities-310815-4659291/ 2015-08-31T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-and-google-partner-to-improve-diabetes-treatment-010815-4659734/ 2015-08-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-acquires-us-otc-scar-management-brand-scaraway-010915-4660131/ 2015-09-01T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/laccure-develops-new-product-for-bacterial-vaginosis-treatment-010915-4660192/ 2015-09-01T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/agile-completes-patient-recruitment-in-twirla-phase-3-secure-clinical-trial-010915-4660216/ 2015-09-01T05:24:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-secures-right-to-buy-promedior-in-125bn-010915-4660261/ 2015-09-01T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/lipocine-submits-nda-for-lpcn-1021-oral-testosterone-replacement-product-candidate-010915-4660552/ 2015-09-01T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/ascletis-secures-tfda-nod-to-begin-phase-ii-trial-of-interferon-free-hcv-regimen-010915-4660585/ 2015-09-01T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/atara-biotherapeutics-completes-enrollment-in-pinta-745-phase-2-clinical-trial-010915-4660597/ 2015-09-01T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/ul-signs-training-partnership-with-central-drugs-standards-control-organization-010915-4660611/ 2015-09-01T08:37:00+00:00 https://www.pharmaceutical-business-review.com/news/soligenix-completes-patient-enrollment-into-phase-2-clinical-trial-of-sgx942-010915-4660616/ 2015-09-01T08:43:00+00:00 https://www.pharmaceutical-business-review.com/news/oncoceutics-secures-grant-for-phase-ii-brain-cancer-trial-020915-4664785/ 2015-09-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alexion-secures-approvals-to-market-two-new-drugs-in-europe-020915-4660859/ 2015-09-02T01:04:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/boehringer-selects-vectrons-expression-technology-platform-020915-4661279/ 2015-09-02T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/laccures-otc-product-for-bacterial-vaginosis-ready-for-market-launch-020915-4661330/ 2015-09-02T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-amgen-collaborate-on-alzheimers-and-migraine-treatment-020915-4661386/ 2015-09-02T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/audentes-therapeutics-acquires-cardiogen-sciences-020915-4661441/ 2015-09-02T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-acquires-gsks-opiates-business-in-australia-020915-4661697/ 2015-09-02T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/viking-therapeutics-starts-vk5211-clinical-development-program-020915-4661727/ 2015-09-02T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/heat-biologics-starts-clinical-trial-combining-hs-110-and-pd-1-checkpoint-inhibitor-in-nsclc-020915-4661741/ 2015-09-02T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/xerox-acquires-inventiv-patient-access-solutions-020915-4661753/ 2015-09-02T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/ocata-wins-sbir-grant-to-develop-photoreceptor-progenitor-cell-therapy-for-retinitis-pigmentosa-020915-4661774/ 2015-09-02T08:18:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/novimmune-signs-international-research-collaboration-deal-with-baxalta-030915-4664769/ 2015-09-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/cleveland-biolabs-wins-deal-for-advanced-development-of-entolimod-towards-full-licensure-030915-4664851/ 2015-09-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/surefire-medical-gets-fda-clearance-for-surefire-precision-030915-4667442/ 2015-09-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-novartis-revolade-for-severe-aplastic-anemia-030915-4662069/ 2015-09-03T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/lannett-to-buy-kremers-urban-pharmaceuticals-for-123bn-030915-4662511/ 2015-09-03T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/suven-starts-phase-1-clinical-trial-of-alzheimers-drug-in-us-030915-4662579/ 2015-09-03T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/dicerna-submits-ind-application-for-dcr-ph1-therapeutic-candidate-030915-4662622/ 2015-09-03T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-tesaros-chemotherapy-anti-nausea-drug-030915-4662661/ 2015-09-03T05:26:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/globaldata-says-antisense-rnai-therapeutics-deals-value-reached-56bn-in-2014-030915-4662845/ 2015-09-03T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-submits-maa-for-novel-intravenous-calcimimetic-etelcalcetide-amg-416-030915-4662952/ 2015-09-03T08:32:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/daiichi-sankyo-signs-deal-to-market-astrazenecas-flumist-in-japan-030915-4663015/ 2015-09-03T08:43:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-invests-74m-in-denmark-warehouse-040915-4663331/ 2015-09-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-closes-acquisition-of-hospira-for-15bn-040915-4663337/ 2015-09-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-teams-up-with-md-anderson-cancer-center-for-cancer-immnotherapy-040915-4663413/ 2015-09-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-secures-us-fda-approval-for-brilinta-for-long-term-use-040915-4663419/ 2015-09-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/redx-pharma-forms-cancer-research-collaboration-with-horizon-discovery-group-040915-4664867/ 2015-09-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/researchers-develop-targeted-drug-delivery-to-lung-040915-4667431/ 2015-09-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/clinical-phase-i-dosing-of-glenmark-pharmaceuticals-gnr-830-completed-in-netherlands-040915-4663444/ 2015-09-04T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-extends-prescription-drug-user-fee-act-date-for-alexions-kanuma-070915-4669249/ 2015-09-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/first-us-patient-treated-with-brainlabs-new-automatic-brain-metastases-planning-software-070915-4669250/ 2015-09-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alvogen-launches-first-generic-exelon-patch-in-us-070915-4669251/ 2015-09-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/igi-laboratories-submits-seventh-anda-to-us-fda-070915-4669252/ 2015-09-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cipla-to-buy-two-us-pharmaceutical-firms-for-550m-070915-4664032/ 2015-09-07T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/enwave-starts-manufacturing-phase-of-deal-with-sutro-biopharma-070915-4664338/ 2015-09-07T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-wins-eu-approval-for-multiple-myeloma-drug-farydak-070915-4664393/ 2015-09-07T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-wins-us-fda-breakthrough-therapy-designation-for-ace910-070915-4664456/ 2015-09-07T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-accepts-priority-review-to-janssens-bla-for-daratumumab-070915-4664497/ 2015-09-07T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/cancer-drugs-fund-removes-funding-for-two-myeloma-drugs-070915-4664666/ 2015-09-07T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/absorb-health-adds-new-supplements-to-inventory-070915-4664816/ 2015-09-07T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/yabao-and-university-of-south-australia-partner-to-develop-new-treatments-for-cancer-070915-4664835/ 2015-09-07T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-unveils-further-evidence-for-azd9291-potential-in-first-line-and-pre-treated-nsclc-080915-4669245/ 2015-09-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pacira-pharmaceuticals-sues-us-fda-over-exparel-product-rights-080915-4669246/ 2015-09-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aerie-pharmaceuticals-and-ramot-at-tel-aviv-university-form-research-collaboration-080915-4669247/ 2015-09-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/international-stem-cell-enters-into-second-phase-of-research-deal-with-rohto-pharmaceutical-080915-4669248/ 2015-09-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazeneca-and-starpharma-sign-drug-delivery-technology-deal-080915-4665085/ 2015-09-08T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/audion-therapeutics-secures-funds-to-advance-hearing-loss-treatment-program-080915-4665377/ 2015-09-08T04:24:00+00:00 https://www.pharmaceutical-business-review.com/news/amra-and-pfizer-form-novel-research-alliance-080915-4665428/ 2015-09-08T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/endocyte-unveils-final-os-results-from-phase-2b-target-trial-in-nsclc-patients-080915-4665465/ 2015-09-08T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/india-rejects-pfizers-new-patent-application-for-tofacitinib-arthritis-drug-080915-4665512/ 2015-09-08T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/recipharm-negotiates-with-alcon-om-manufacturing-deal-080915-4665717/ 2015-09-08T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-mit-to-undertake-research-on-next-generation-of-drug-delivery-devices-080915-4665761/ 2015-09-08T07:09:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/concordia-healthcare-to-buy-amdipharm-mercury-for-35bn-080915-4665897/ 2015-09-08T08:36:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-starts-work-on-new-pharmaceutical-factory-in-india-090915-4669168/ 2015-09-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/agilent-technologies-to-buy-seahorse-bioscience-090915-4669244/ 2015-09-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/recipharm-signs-manufacturing-deal-with-lobsor-090915-4666068/ 2015-09-09T00:36:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-pfizer-sign-license-and-collaboration-deal-in-tissue-fibrosis-090915-4666520/ 2015-09-09T04:21:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazeneca-and-university-of-manchester-form-clinical-bioinformatics-partnership-090915-4666575/ 2015-09-09T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/debiopharm-solid-biosciences-to-explore-use-of-alisporivir-in-muscular-dystrophy-090915-4666624/ 2015-09-09T05:03:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/biogen-licenses-mitsubishi-tanabes-autoimmune-therapeutic-agent-090915-4666707/ 2015-09-09T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/scottish-medicines-consortium-approves-sanofis-toujeo-insulin-090915-4666972/ 2015-09-09T07:00:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/almost-50-of-testicular-cancer-risk-is-passed-down-through-genetic-faults-study-090915-4667022/ 2015-09-09T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/dndi-completes-phase-i-human-clinical-trials-for-scyx-7158-090915-4667048/ 2015-09-09T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/walvax-adopts-medidatas-technology-platform-for-pediatric-vaccine-program-in-china-090915-4667100/ 2015-09-09T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/gene-therapy-firm-avexis-secures-65m-in-financing-090915-4667110/ 2015-09-09T08:14:00+00:00 https://www.pharmaceutical-business-review.com/news/certara-and-paidion-research-partner-to-improve-pediatric-drug-development-100915-4669242/ 2015-09-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/sernova-secures-commercial-rights-to-stem-cell-derived-technologies100915-4669243/ 2015-09-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-submits-maa-to-european-medicines-agency-for-daratumumab-in-multiple-myeloma-100915-4667390/ 2015-09-10T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/integral-biosystems-secures-phase-i-sbir-grant-to-develop-glaucoma-treatment-drug-100915-4667486/ 2015-09-10T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/novadip-secures-28m-financing-to-advance-clinical-development-of-creost-100915-4667786/ 2015-09-10T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/revance-starts-phase-2-clinical-trial-of-rt001-in-axillary-hyperhidrosis-100915-4667830/ 2015-09-10T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-pfizer-start-phase-4-augustus-trial-of-eliquis-100915-4667888/ 2015-09-10T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/epirus-biopharmaceuticals-acquires-bioceros-100915-4668031/ 2015-09-10T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/omega-pharma-seeks-ce-mark-designation-for-bl-5010-100915-4668056/ 2015-09-10T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/biolinerx-files-regulatory-submissions-for-phase-2-trial-of-bl-8040-100915-4668103/ 2015-09-10T07:04:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/apricus-biosciences-reacquires-us-rights-to-vitaros-from-allergan-100915-4668155/ 2015-09-10T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/envision-pharma-acquires-alligent-biopharm-consulting-100915-4668176/ 2015-09-10T07:36:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/vaccinogen-signs-option-deal-with-dublin-city-university-to-acquire-dicast-platform-100915-4668196/ 2015-09-10T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-allergans-abbreviated-ndas-for-three-mucinex-equivalent-products-110915-4669240/ 2015-09-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nanostring-launches-ncounter-rnaprotein-pancancer-immune-profiling-panel-110915-4669241/ 2015-09-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-label-update-for-bristol-myers-squibbs-daklinza-110915-4668455/ 2015-09-11T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-and-johnson-to-open-first-canadian-jlabs-incubator-in-ontario-110915-4668751/ 2015-09-11T04:36:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/teva-pharmaceutical-and-ibm-collaborate-on-watson-health-cloud-110915-4668791/ 2015-09-11T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-grants-orphan-drug-status-to-stemlines-sl-401-for-aml-treatment-110915-4668829/ 2015-09-11T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/summit-therapeutics-completes-patient-enrollment-for-smt19969-phase-2-trial-110915-4668862/ 2015-09-11T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-buys-us-biologics-bulk-manufacturing-plant-from-amgen-110915-4669144/ 2015-09-11T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-grants-fast-track-designation-to-aridis-ar-301-product-candidate-110915-4669160/ 2015-09-11T08:12:00+00:00 https://www.pharmaceutical-business-review.com/news/cms-approves-wolters-kluwers-drug-database-as-oncology-compendium-110915-4669188/ 2015-09-11T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/university-of-connecticut-partners-with-yale-university-on-drug-research-initiative-110915-4669198/ 2015-09-11T08:41:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/university-of-queensland-scientists-close-in-on-first-dengue-treatment-110915-4669200/ 2015-09-11T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/gencia-takeda-partner-to-develop-magr-drugs-as-alternatives-to-steroids-140915-4669455/ 2015-09-14T02:28:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/mundipharma-medical-developments-partner-to-commercialize-penthrox-in-europe-140915-4669948/ 2015-09-14T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/vaccibody-vaccinates-first-patient-in-phase-iiia-study-vb1016-immunotherapy-140915-4669862/ 2015-09-14T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofis-combination-diabetes-drug-hits-target-in-second-phase-iii-study-140915-4669880/ 2015-09-14T05:38:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/jubilant-draximage-signs-term-sheet-with-cyclopharm-for-license-to-market-technegas-in-us-140915-4670249/ 2015-09-14T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-voted-unanimously-to-support-approval-of-collegium-pharmaceuticals-xtampza-140915-4670252/ 2015-09-14T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-submits-application-to-fda-seeking-approval-of-repatha-injection-140915-4670261/ 2015-09-14T08:28:00+00:00 https://www.pharmaceutical-business-review.com/news/research-shows-potential-misuse-and-abuse-of-other-medications-and-drugs-in-prescribed-opioids-140915-4670266/ 2015-09-14T08:34:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/new-drug-approach-can-prevent-antibiotic-resistance-140915-4670268/ 2015-09-14T08:36:00+00:00 https://www.pharmaceutical-business-review.com/news/psychogenics-extends-drug-discovery-collaboration-with-sunovion-150915-4674076/ 2015-09-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sengenics-oxford-gene-technologys-protein-array-technology-150915-4674103/ 2015-09-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/zenyaku-terminates-blisibimod-development-deal-with-anthera-pharmaceuticals-150915-4670516/ 2015-09-15T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/raptor-stops-developing-rp103-drug-after-it-fails-to-treat-nonalcoholic-steatohepatitis-in-children-150915-4670809/ 2015-09-15T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-starts-offer-to-buy-perrigo-150915-4670946/ 2015-09-15T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/domainex-auspherix-expand-partnership-to-develop-new-drugs-for-bacterial-infections-150915-4670883/ 2015-09-15T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-millipore-enhances-emprove-portfolio-of-pharmaceutical-raw-materials-150915-4671080/ 2015-09-15T06:40:00+00:00 https://www.pharmaceutical-business-review.com/news/chiltern-acquires-theorem-clinical-research-150915-4671159/ 2015-09-15T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/parexels-board-approves-200m-common-stock-buyback-150915-4671174/ 2015-09-15T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/erytech-submits-maa-to-european-medicines-agency-for-graspa-150915-4671300/ 2015-09-15T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-agrees-to-review-vanda-pharmaceuticals-snda-for-fanapt-150915-4671282/ 2015-09-15T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-unveils-positive-initial-clinical-results-for-aln-as1-160915-4672753/ 2015-09-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/second-part-of-portolas-phase-3-annexa-r-study-meets-primary-and-secondary-endpoints-160915-4672757/ 2015-09-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-acheives-full-enrollment-in-phase-2-alta-trial-of-brigatinib-160915-4672763/ 2015-09-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alector-raised-32m-in-series-c-financing-160915-4672769/ 2015-09-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cardinal-health-launches-hospital-quality-at-home-products-160915-4675967/ 2015-09-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-agrees-to-buy-insite-vision-160915-4671569/ 2015-09-16T01:51:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/crucell-holland-secures-barda-funding-to-speed-up-ebola-vaccine-regimen-4672094/ 2015-09-16T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/xenoport-xp23829-psoriasis-drug-shows-side-effects-160915-4672009/ 2015-09-16T05:17:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/daiichi-sankyo-licenses-ts23-thrombus-dissolving-agent-from-translational-sciences-160915-4672185/ 2015-09-16T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/glenmark-submits-clinical-trial-application-for-gbr-1302-novel-antibody-160915-4672387/ 2015-09-16T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/intra-cellular-says-higher-dose-of-iti-007-can-be-effective-to-treat-schizophrenia-170915-4672498/ 2015-09-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nurix-celgene-partner-to-develop-new-therapies-for-oncology-immunology-and-immuno-oncology-170915-4672538/ 2015-09-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-therapy-designation-to-bristol-myers-squibbs-opdivo-170915-4672573/ 2015-09-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-and-xencor-form-175bn-cancer-drug-collaboration-170915-4672606/ 2015-09-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/suven-life-sciences-secures-three-product-patents-in-canada-and-china-170915-4673840/ 2015-09-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bionomics-bnc210-phase-1-trial-for-anxiety-and-depression-meets-primary-and-secondary-endpoints-170915-4672927/ 2015-09-17T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/ocera-starts-phase-1-clinical-trial-of-ocr-002-oral-drug-candidate-170915-4672936/ 2015-09-17T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/cesca-therapeutics-partners-with-with-sloan-kettering-on-stem-cell-purification-applications-170915-4672940/ 2015-09-17T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/novabay-pharmaceuticals-signs-deal-with-alldocs-optometry-group-170915-4672942/ 2015-09-17T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-to-buy-forbion-capital-partners-portfolio-firm-dezima-pharma-170915-4672945/ 2015-09-17T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/cell-signaling-technology-releases-vista-rabbit-monoclonal-antibody-170915-4672948/ 2015-09-17T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/selvita-establishes-first-operations-in-us-180915-4674065/ 2015-09-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-opens-new-biomanufacturing-facility-in-austria-180915-4674092/ 2015-09-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/health-canada-starts-review-of-ptc-therapeutics-nds-for-translarna-180915-4674127/ 2015-09-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/clinigen-forms-alliance-with-cumberland-pharmaceuticals-180915-4675039/ 2015-09-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-secures-swissmedic-approval-for-entresto-heart-failure-medicine-180915-4673299/ 2015-09-18T02:52:00+00:00 https://www.pharmaceutical-business-review.com/news/first-patient-in-vivoluxs-study-completes-treatment-at-third-dose-level-of-vlx1570-drug-candidate-180915-4673530/ 2015-09-18T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/tg-therapeutics-signs-special-protocol-assessment-agreement-with-us-fda-180915-4673556/ 2015-09-18T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/can-fite-secures-fda-fast-track-designation-for-cf102-in-hcc-180915-4673570/ 2015-09-18T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/m-pharmaceutical-to-request-dtc-eligibility-to-enhance-iquidity-on-otcqb-180915-4673760/ 2015-09-18T07:19:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/mckesson-to-buy-pharmaceutical-distribution-unit-of-udg-healthcare-180915-4673823/ 2015-09-18T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/lfb-announces-first-marketing-authorizations-in-europe-for-iqymune-210915-4675801/ 2015-09-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-secures-24m-option-grant-from-darpa-to-advance-ebola-program-development-210915-4675824/ 2015-09-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/xenon-achieves-milestone-in-genentech-collaboration-to-discover-novel-pain-targets-210915-4675840/ 2015-09-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-rejects-mylans-unsolicited-exchange-offer-as-inadequate-210915-4676028/ 2015-09-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-house-committee-oks-reversal-of-ban-on-otcs-in-health-savings-accounts-210915-4676094/ 2015-09-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgens-snda-for-expanded-labeling-of-kyprolis-cancer-drug-granted-priority-review-210915-4674033/ 2015-09-21T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-to-sell-ranbaxys-two-cns-divisions-to-strides-arcolab-210915-4674492/ 2015-09-21T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-wins-approval-to-market-intuniv-adhd-medicine-in-europe-210915-4674570/ 2015-09-21T05:08:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/mercks-bezlotoxumab-antibody-meets-primary-endpoint-in-two-studies-210915-4674652/ 2015-09-21T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/clinigen-partners-with-neuraltus-to-provide-access-to-new-als-drug-in-europe-210915-4674974/ 2015-09-21T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/nextera-forms-research-collaboration-with-johnson-johnson-innovation-210915-4675040/ 2015-09-21T08:42:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-gets-us-fda-clia-waiver-for-cobas-influenza-ab-test-220915-4675395/ 2015-09-22T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/innovate-uk-awards-19m-grant-to-mission-therapeutics-for-dub-cancer-program-220915-4675650/ 2015-09-22T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ub-spinoff-cytocybernetics-tests-new-biotechnology-to-enhance-drug-safety-screening-220915-4675696/ 2015-09-22T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-to-release-preclinical-data-from-over-50-medicines-as-part-of-dream-challenge-220915-4675777/ 2015-09-22T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/us-health-department-advances-development-of-new-antibody-treatment-for-ebola-220915-4676113/ 2015-09-22T07:47:00+00:00 https://www.pharmaceutical-business-review.com/news/h3-biomedicine-selvita-expand-precision-cancer-medicines-alliance-220915-4676156/ 2015-09-22T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/stanford-university-researchers-re-engineer-virus-to-deliver-therapies-to-cells-220915-4676166/ 2015-09-22T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/nmi-tt-pharmaservices-opens-new-branch-in-berlin-germany-220915-4676190/ 2015-09-22T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/palatin-and-richter-terminate-license-deal-for-bremelanotide-220915-4676206/ 2015-09-22T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/bioclinica-acquires-synowledge-230915-4678360/ 2015-09-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/study-finds-initial-prescription-fills-can-accurately-predict-long-term-medication-adherence-230915-4681645/ 2015-09-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ruiyi-doses-first-patient-in-double-blinded-trial-of-gerilimzumab-to-treat-arthritis-230915-4676481/ 2015-09-23T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-to-construct-70m-manufacturing-facility-in-iran-230915-4676903/ 2015-09-23T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-perrigos-generic-version-of-valeants-benzaclin-gel-230915-4676939/ 2015-09-23T05:18:00+00:00 https://www.pharmaceutical-business-review.com/news/taiho-oncology-gets-us-fda-nod-for-lonsurf-refractory-colorectal-cancer-drug-230915-4676979/ 2015-09-23T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/deciphera-secures-75m-financing-to-advance-novel-oncology-pipeline-230915-4677313/ 2015-09-23T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/heron-therapeutics-htx-011-pain-drug-succeeds-in-phase-2-clinical-study-230915-4677305/ 2015-09-23T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-reports-positive-data-on-sofosbuvir-and-velpatasvir-inhibitors-230915-4677323/ 2015-09-23T08:12:00+00:00 https://www.pharmaceutical-business-review.com/news/synthetic-genomics-expands-research-and-development-deal-with-lung-biotechnology-pbc-230915-4677329/ 2015-09-23T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/idt-biologika-opens-new-manufacturing-facility-in-us-230915-4677347/ 2015-09-23T08:31:00+00:00 https://www.pharmaceutical-business-review.com/news/cvspharmacy-commits-to-create-safer-communities-via-drug-abuse-prevention-efforts-240915-4681628/ 2015-09-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/purdue-pharma-anabios-start-program-to-accelerate-development-of-chronic-pain-treatment-240915-4681616/ 2015-09-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-sayana-press-self-injectable-contraceptive-available-in-uk-240915-4677698/ 2015-09-24T02:19:00+00:00 https://www.pharmaceutical-business-review.com/news/uks-nice-recommends-daiichi-sankyos-lixiana-blood-thinning-drug-240915-4677953/ 2015-09-24T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/neovacs-starts-phase-iib-trial-of-ifn-kinoid-to-treat-lupus-240915-4677990/ 2015-09-24T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-allergan-achieve-endpoints-in-abp-215-biosimilar-candidate-study-240915-4678019/ 2015-09-24T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/chpa-educational-foundation-survey-offers-insight-on-otc-medicines-230915-4678044/ 2015-09-24T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/essa-pharma-wins-fda-approval-to-start-clinical-development-of-epi-506-240915-4678368/ 2015-09-24T08:34:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-keryxs-fexeric-for-elevated-serum-phosphorous-240915-4678350/ 2015-09-24T08:42:00+00:00 https://www.pharmaceutical-business-review.com/news/erytech-pharma-wins-us-patent-for-erythrocytes-containing-arginine-deiminase-240915-4678375/ 2015-09-24T08:43:00+00:00 https://www.pharmaceutical-business-review.com/news/regen-biopharma-starts-small-molecule-hit-validation-study-on-cancer-stem-cell-target-gene-240915-4678383/ 2015-09-24T08:52:00+00:00 https://www.pharmaceutical-business-review.com/news/gsks-asthma-drug-gets-marketing-authorization-in-europe-250915-4678481/ 2015-09-25T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/uks-nice-recommends-gileads-zydelig-to-treat-chronic-lymphocytic-leukaemia-in-adults-250915-4678541/ 2015-09-25T02:36:00+00:00 https://www.pharmaceutical-business-review.com/news/immunocellular-secures-grant-for-clinical-trial-of-glioblastoma-250915-4678611/ 2015-09-25T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/us-appeals-court-upholds-shires-patents-for-vyvanse-drug-250915-4678695/ 2015-09-25T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/xenon-pharmaceuticals-starts-xen801-phase-1-clinical-trial-250915-4679052/ 2015-09-25T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/replimune-raises-30m-series-a-financing-4679069/ 2015-09-25T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/mrc-technology-university-of-lausanne-partner-to-find-drug-treatment-for-lymphoma-250915-4679076/ 2015-09-25T04:59:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/syros-pharmaceuticals-licenses-clinical-stage-rar-agonist-250915-4679092/ 2015-09-25T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-exercises-option-to-license-bind-therapeutics-accurin-drug-candidate-250915-4679039/ 2015-09-25T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-two-new-drug-treatments-for-diabetes-mellitus-280915-4681696/ 2015-09-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/medimmune-3m-drug-delivery-systems-partner-to-develop-novel-tlr-agonist-cancer-therapies-280915-4681744/ 2015-09-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-praluent-anti-cholesterol-drug-280915-4679821/ 2015-09-28T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-recommends-novartis-entresto-heart-failure-medicine-for-eu-approval-280915-4680266/ 2015-09-28T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-receives-chmp-positive-opinions-for-two-new-blood-cancer-treatment-options-280915-4680291/ 2015-09-28T05:53:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/peptidream-and-teijin-pharma-sign-peptide-discovery-collaboration-deal-280915-4680560/ 2015-09-28T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-unveils-results-of-phase-iii-pivotal-study-of-afinitor-280915-4680596/ 2015-09-28T08:37:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-bristol-myers-squibbs-immunotherapy-opdivo-nivolumab-280915-4680604/ 2015-09-28T08:45:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-and-pfizer-secure-fda-orphan-drug-designation-for-avelumab-280915-4680616/ 2015-09-28T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/vtesse-starts-phase-2b3-clinical-trial-of-vts-270-to-treat-npc-disease-280915-4680490/ 2015-09-28T08:56:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/marina-biotech-and-hongene-biotechnology-sign-license-deal-290915-4682349/ 2015-09-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nybc-howard-and-abby-milstein-foundation-to-advance-use-of-specialized-stem-cell-lines-in-regenerative-medicine-290915-4682387/ 2015-09-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-and-sanofi-settle-basaglar-insulin-product-lawsuit-290915-4680928/ 2015-09-29T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/pcori-approves-83m-for-hepatitis-c-and-other-studies-290915-4681193/ 2015-09-29T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/intrexon-ziopharm-partner-to-develop-immunotherapies-to-treat-gvhd-290915-4681306/ 2015-09-29T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/ablynx-starts-phase-iii-study-of-caplacizumab-to-treat-acquired-ttp-290915-4681388/ 2015-09-29T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/us-federal-judge-enters-permanent-injunction-against-sunset-natural-products-290815-4681582/ 2015-09-29T07:08:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/study-finds-maintaining-healthy-dna-delays-menopause-290915-4681688/ 2015-09-29T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-secures-grant-to-support-rsv-f-vaccine-development-290915-4681730/ 2015-09-29T08:39:00+00:00 https://www.pharmaceutical-business-review.com/news/mesoblasts-mpc-therapy-trial-reports-better-cardioprotective-effect-300915-4682008/ 2015-09-30T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/researchers-develop-brain-prosthesis-to-help-memory-loss-patients-300915-4682250/ 2015-09-30T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-starts-tender-offer-to-buy-insite-vision-300915-4682330/ 2015-09-30T04:55:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astellas-pharma-chromocell-partner-to-develop-neuropathic-pain-therapies-300915-4682438/ 2015-09-30T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-wins-approval-for-copaxone-to-prevent-relapse-of-multiple-sclerosis-300915-4682774/ 2015-09-30T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-orphan-drug-designation-to-zafgens-beloranib-to-treat-craniopharyngioma-300915-4682706/ 2015-09-30T08:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ubivac-forms-collaboration-with-johnson-johnson-innovation-300915-4682783/ 2015-09-30T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/corvus-pharmaceuticals-closes-75m-series-b-financing-300915-4682788/ 2015-09-30T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/gtx-enrolls-first-patient-in-phase-2-clinical-trial-of-enobosarm-in-erar-breast-cancer-300915-4682799/ 2015-09-30T08:28:00+00:00 https://www.pharmaceutical-business-review.com/news/accelerator-secures-117m-in-new-investment-commitments-300915-4682823/ 2015-09-30T08:44:00+00:00 https://www.pharmaceutical-business-review.com/news/illumina-introduces-trusight-tumor-15-panel-300915-4682827/ 2015-09-30T08:49:00+00:00 https://www.pharmaceutical-business-review.com/news/vitae-starts-second-part-of-phase-1-study-of-vtp-43742-in-psoriatic-patients-300915-4682834/ 2015-09-30T08:53:00+00:00 https://www.pharmaceutical-business-review.com/news/cadca-raises-awareness-of-dangers-of-prescription-rx-drug-and-otc-cough-medicine-abuse-011015-4684288/ 2015-09-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/vetter-to-invest-eur300m-to-upgrade-manufacturing-facilities-011015-4683073/ 2015-10-01T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-exercises-option-for-inhaled-therapeutics-from-liquidia-technologies-011015-4683171/ 2015-10-01T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/aspen-park-acquires-rights-to-novel-oral-drug-to-treat-castration-resistant-prostate-cancer-011015-4683446/ 2015-10-01T03:57:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-pharmaceuticals-acquires-novartis-vaccines-business-011015-4683682/ 2015-10-01T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/ptc-therapeutics-gets-ema-validation-for-translarna-cystic-fibrosis-drug-011015-4683752/ 2015-10-01T08:22:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/domp-and-omega-pharma-sign-otc-product-range-marketing-deal-011015-4684123/ 2015-10-01T09:06:00+00:00 https://www.pharmaceutical-business-review.com/news/new-data-shows-sustained-long-term-efficacy-of-ofev-nintedanib-011015-4684127/ 2015-10-01T09:11:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-releases-draft-guideline-for-public-consultation-to-accelerate-antibiotics-development-011015-4684129/ 2015-10-01T09:14:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/symplmed-puracap-pharmaceutical-team-up-to-distribute-new-epiceram-l-lip-care-011015-4684132/ 2015-10-01T09:19:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-return-kuvan-drug-rights-to-biomarin-pharmaceutical-021015-4683936/ 2015-10-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ferring-to-commercialize-apricus-vitaros-ed-cream-in-latin-america-021015-4684006/ 2015-10-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-opts-into-alnylams-aln-at3-hemophilia-program-021015-4684111/ 2015-10-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-bristol-myers-squibbs-opdivo-nivolumab-yervoy-ipilimumab-regimen-021015-4684277/ 2015-10-02T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/santhera-pharmaceuticals-launches-raxone-in-germany-021015-4684278/ 2015-10-02T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-agrees-to-acquire-rimsa-for-23bn-021015-4684282/ 2015-10-02T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/biohaven-and-fccdc-form-alliance-in-early-stage-drug-discovery-research-021015-4684286/ 2015-10-02T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/neon-therapeutics-secures-55m-to-develop-neoantigen-based-cancer-immunotherapies-021015-4684086/ 2015-10-02T13:29:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmalink-raises-funds-to-advance-nefecon-development-to-treat-kidney-disease-021015-4684032/ 2015-10-02T13:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-drops-divisional-brands-151015-4694209/ 2015-10-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/theralase-completes-gmp-manufacture-of-second-batch-of-lead-drug-051015-4684292/ 2015-10-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/karo-bio-acquires-otc-products-manufacturer-swereco-051015-4684297/ 2015-10-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-buys-us-rights-of-moxatag-from-pragma-pharmaceuticals-051015-4684322/ 2015-10-05T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-sandozs-bla-for-biosimilar-etanercept-051015-4684328/ 2015-10-05T00:13:00+00:00 https://www.pharmaceutical-business-review.com/news/ultragenyx-seeks-marketing-authorization-for-ace-er-tablets-in-europe-051015-4684429/ 2015-10-05T02:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-treatment-combination-of-gileads-letairis-with-tadalafil-for-pah-051015-4684428/ 2015-10-05T02:29:00+00:00 https://www.pharmaceutical-business-review.com/news/anthera-starts-phase-3-study-of-sollpura-pancreatic-enzyme-replacement-therapy-051015-4684427/ 2015-10-05T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-keytruda-for-treatment-of-patients-with-metastatic-non-small-cell-lung-cancer-whose-tumors-express-pd-l1-with-disease-progression-on-or-after-platinum-containing-chemotherapy-051015-46853/ 2015-10-05T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/dako-announces-fda-approval-of-new-companion-diagnostic-for-lung-cancer-051015-4685326/ 2015-10-05T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/william-campbell-satoshi-mura-and-youyou-tu-win-2015-nobel-prize-in-physiology-or-medicine-4685836/ 2015-10-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/protalex-to-start-phase-ib-trial-of-immune-thrombocytopenia-drug-in-france-061015-4686017/ 2015-10-06T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-to-pay-14m-to-settle-charges-on-bribery-in-china-100615-4686134/ 2015-10-06T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/raptor-acquires-fluoroquinolone-antibiotic-quinsair-from-tripex-061015-4686197/ 2015-10-06T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/otonomy-gets-fda-approval-to-begin-phase-i-trial-of-tinnitus-product-candidate-oto-311-061015-4686279/ 2015-10-06T05:47:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/johnson-matthey-acquires-pharmorphix-061015-4686622/ 2015-10-06T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/baxalta-and-momenta-announce-initiation-of-pivotal-clinical-trial-for-m923-a-biosimilar-version-of-humira-061015-4686634/ 2015-10-06T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/mcguff-pharmaceuticals-announces-fda-approval-for-hydroxyprogesterone-caproate-injection-usp-061015-4686647/ 2015-10-06T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/amerisourcebergen-to-acquire-pharmedium-for-25bn-071015-4687016/ 2015-10-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gtx-enrolls-first-patient-in-phase-ii-enobosarm-trial-to-treat-triple-negative-breast-cancer-071015-4687441/ 2015-10-07T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/osiris-therapeutics-begins-phase-iii-trial-of-oti-15-01-for-treatment-of-diabetic-foot-ulcers-071015-4687427/ 2015-10-07T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/tarix-orphan-obtains-fda-fast-track-status-for-txa127-to-treat-dmd-071015-4687378/ 2015-10-07T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-daklinza-sndas-gets-fda-priority-review-071015-4687284/ 2015-10-07T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/acelrx-announces-initiation-of-clinical-study-with-arx-04-in-emergency-room-patients-with-moderate-to-severe-acute-pain-071015-4687707/ 2015-10-07T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-therapeutics-completes-enrollment-for-bti-320-clinical-trial-4687830/ 2015-10-07T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/skin-cancer-drug-pembrolizumab-obtains-nice-approval-081015-4688159/ 2015-10-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-starts-phase-iii-riociguat-trial-to-treat-pah-in-children-081015-4688409/ 2015-10-08T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-pfizer-receive-fda-fast-track-status-for-avelumab-to-treat-merkel-cell-carcinoma-081015-4688393/ 2015-10-08T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-benitec-partner-to-develop-aav-manufacturing-process-for-ddrnai-therapeutics-081015-4688469/ 2015-10-08T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/russia-approves-three-times-a-week-copaxone-40-mgml-for-treatment-of-rrms-091015-4689573/ 2015-10-09T02:42:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-grants-breakthrough-therapy-designation-for-lillys-abemaciclib-091015-4689592/ 2015-10-09T02:47:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-begins-phase-i-ole-trial-of-aln-at3-to-treat-haemophilia-091015-4689627/ 2015-10-09T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-signs-deal-with-immunomic-therapeutics-for-worlwide-license-of-lamp-vax-091015-4689475/ 2015-10-09T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-begins-clinical-trial-of-ebola-vaccine-regimen-in-sierra-leone-121015-4690515/ 2015-10-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/roche-to-acquire-adheron-therapeutics-for-580m-121015-4690317/ 2015-10-11T22:36:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myerss-opdivo-injection-gets-fda-approval-for-nsclc-treatment-121015-4690481/ 2015-10-12T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-path-completes-patient-enrollment-in-cohort-seven-of-liposomal-grb-2s-phase-ib-trial-121015-4690767/ 2015-10-12T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-innovent-expand-collaboration-to-develop-immune-oncology-bispecific-antibodies-121015-4690548/ 2015-10-12T03:01:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-submits-european-application-for-antiseptic-chlorhexidine-gel-131015-4691715/ 2015-10-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-to-discontinue-development-of-heart-drug-evacetrapib-131015-4691492/ 2015-10-12T22:35:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-to-invest-another-15m-in-israels-gamida-cell-131015-4691586/ 2015-10-13T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/clearside-completes-patient-enrollment-in-dogwood-trial-of-cls-ta-for-treatment-of-macular-edema-131015-4691770/ 2015-10-13T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/scottish-medicines-consortium-accepts-six-new-medicines-for-routine-use-131015-4691830/ 2015-10-13T01:50:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/uks-nice-launches-office-for-market-access-for-faster-development-of-drugs-141015-4693050/ 2015-10-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sphaera-pharma-receives-notice-of-allowance-from-uspto-for-drug-modification-platform-technology-141015-4698274/ 2015-10-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-to-shires-injectable-prescription-medicine-cinryze-141015-4692716/ 2015-10-13T22:24:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaroth-labs-announces-approval-of-sucanon-in-canada-141015-4693036/ 2015-10-14T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-pharmaceuticals-acquires-iforce-nutrition-141015-4693056/ 2015-10-14T01:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-imaginab-enter-into-preclinical-immuno-oncology-research-deal-141015-4692985/ 2015-10-14T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/oicr-novera-and-janssen-biotech-collaborate-to-develop-haematological-cancer-drug-151015-4693923/ 2015-10-15T03:33:00+00:00 https://www.pharmaceutical-business-review.com/news/crown-bioscience-expands-cardiovascular-and-metabolic-disease-capabilities-151015-4693960/ 2015-10-15T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-gives-recommendations-for-pfizer-snda-of-xeljanz-to-treat-plaque-psoriasis-151015-4694295/ 2015-10-15T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/incyte-and-merck-expand-clinical-collaboration-to-include-phase-iii-study-investigating-combination-of-epacadostat-with-keytruda-as-first-line-treatment-for-advanced-melanoma-151015-4694418/ 2015-10-15T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-biotech-engene-partner-to-develop-new-therapies-for-inflammatory-bowel-disease-151015-4694381/ 2015-10-15T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/kenya-launches-novartis-access-for-treatment-of-chronic-diseases-151015-4694228/ 2015-10-15T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/corbus-doses-first-patient-in-phase-2-study-of-resunab-for-cystic-fibrosis-treatment-161015-4695286/ 2015-10-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-and-five-prime-partner-for-antibody-program-161015-4695121/ 2015-10-16T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/emisphere-novo-nordisk-to-develop-four-oral-formulations-using-eligen-technology-161015-4695268/ 2015-10-16T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/ptc-announces-result-of-phase-iii-trial-of-translarna-to-nmdmd-161015-4695386/ 2015-10-16T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/integral-molecular-gets-funding-to-advance-development-of-ebola-antibodies-161015-4695459/ 2015-10-16T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/enteris-biopharmas-formulation-technology-enables-oral-delivery-of-tarsa-therapeutics-tbria-191015-4698248/ 2015-10-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/scientists-design-new-delivery-system-for-protease-inhibitors-191015-4698265/ 2015-10-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-receives-fda-complete-response-letter-for-lifitegrast-nda-191015-4699578/ 2015-10-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-basileas-isavuconazole-to-treat-invasive-aspergillosis-and-mucormycosis-191015-4696440/ 2015-10-19T02:11:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-seeks-more-data-on-astrazenecas-diabetes-combination-therapy-191015-4696950/ 2015-10-19T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/inotek-starts-dosing-of-patients-in-trabodenoson-trial-191015-4697004/ 2015-10-19T05:52:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/covance-to-run-iclaprim-phase-iii-trials-for-motif-bio-191015-4697049/ 2015-10-19T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-recommends-bristol-myers-squibbs-daklinza-to-treat-chronic-hepatitis-c-virus-infection-191015-4697378/ 2015-10-19T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/hemispherx-gets-positive-opinion-on-application-for-alferon-n-injection-to-treat-mers-191015-4697400/ 2015-10-19T08:48:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-starts-phase-iia-study-to-evaluate-simeprevir-in-combination-with-odalasvir-and-al-335-191015-4697407/ 2015-10-19T08:52:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/researchers-develop-drug-delivery-technique-to-bypass-blood-brain-barrier-201015-4699497/ 2015-10-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmacyte-to-carry-out-pancreatic-cancer-clinical-trial-in-us-201015-4697793/ 2015-10-20T02:14:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizers-inotuzumab-ozogamicin-gets-fda-breakthrough-status-for-all-201015-4698172/ 2015-10-20T05:13:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/luc-therapeutics-signs-deal-with-novartis-to-accelerate-nr2b-nam-program-201015-4698233/ 2015-10-20T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/agile-therapeutics-completes-enrollment-in-twirla-phase-3-clinical-trial-201015-4698323/ 2015-10-20T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-opens-new-224m-drug-manufacturing-plant-in-russia-201015-4698555/ 2015-10-20T08:22:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-partners-with-unesco-to-build-research-capacity-in-africa-201015-4698573/ 2015-10-20T08:34:00+00:00 https://www.pharmaceutical-business-review.com/news/exact-imaging-riverside-research-partner-to-develop-advanced-tissue-characterization-techniques-for-prostate-cancer-201015-4698587/ 2015-10-20T08:47:00+00:00 https://www.pharmaceutical-business-review.com/news/science-37-secures-funding-to-accelerate-clinical-trial-research-201015-4698591/ 2015-10-20T08:51:00+00:00 https://www.pharmaceutical-business-review.com/news/rio-grande-buys-cervel-neurotechs-multi-coil-tms-technology-to-treat-drug-resistant-depression-211015-4700761/ 2015-10-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-and-six-pharmaceutical-firms-launch-100m-dementia-research-fund-211015-4698998/ 2015-10-21T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/yabao-collaborates-with-eli-lilly-on-diabetes-treatment-211015-4699398/ 2015-10-21T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/synta-pharmaceuticals-stops-lung-cancer-treatment-study-211015-4699443/ 2015-10-21T05:26:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/kite-pharma-nih-announce-worldwide-license-for-tcr-based-products-211015-4699487/ 2015-10-21T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/portal-instruments-closes-financing-to-commercialize-needle-free-drug-delivery-system-211015-4699516/ 2015-10-21T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-boehringer-ingelheims-praxbind-idarucizumab-211015-4699590/ 2015-10-21T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/domainex-imperial-college-london-to-discover-new-therapies-for-myocardial-infarction-211015-4699608/ 2015-10-21T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/jubilant-life-sciences-wins-anda-approval-for-rizatriptan-benzoate-od-tablets-211015-4699750/ 2015-10-21T09:07:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-coagadex-coagulation-factor-x-human-for-hereditary-factor-x-10-deficiency-211015-4699760/ 2015-10-21T09:11:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-unveils-positive-new-data-comparing-incruse-ellipta-to-tiotropium-and-glycopyrronium-in-copd-patients-211015-4699776/ 2015-10-21T09:35:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-acquires-admune-therapeutics-221015-4699658/ 2015-10-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/rxi-pharmaceuticals-selects-two-compounds-for-cosmetic-product-development-221015-4699692/ 2015-10-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/neogenomics-agrees-to-acquire-clarient-221015-4699721/ 2015-10-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/atara-signs-license-and-research-deals-with-australias-qimr-berghofer-institute-221015-4699743/ 2015-10-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-pharmaceuticals-meets-primary-endpoint-in-eli-200-phase-3-study-221015-4699772/ 2015-10-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-impaxs-generic-version-of-intuniv-extended-release-tablets-231015-4700553/ 2015-10-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/oxigene-starts-phase-1b2-clinical-trial-of-oxi4503-in-acute-myeloid-leukemia-221015-4700561/ 2015-10-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/vince-associates-wins-fda-contract-to-conduct-pharmacokinetic-study-with-opioids-221015-4700575/ 2015-10-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/arno-therapeutics-demonstrates-ar-12-has-potent-antiviral-activity-against-drug-resistant-hiv-strains-221015-4700585/ 2015-10-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/athersys-and-chugai-end-license-deal-on-multistem-cell-therapy-development-in-japan-221015-4700989/ 2015-10-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/researchers-say-ultrasound-waves-improve-digestive-drug-delivery-221015-4701010/ 2015-10-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-gets-uspto-patent-for-pennsaid-diclofenac-sodium-topical-solution-2-231015-4701000/ 2015-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-ims-health-partner-to-advance-use-of-real-world-evidence-in-late-stage-clinical-research-231015-4701019/ 2015-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/humana-unveils-real-time-prescription-drug-benefit-service-231015-4701031/ 2015-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/qualidigm-signs-distribution-deal-with-medline-industries-231015-4703470/ 2015-10-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-merrimacks-metastatic-pancreatic-cancer-drug-231015-4700176/ 2015-10-23T02:05:00+00:00 https://www.pharmaceutical-business-review.com/news/worlds-largest-aspirin-anti-cancer-trial-launches-in-uk-231015-4700509/ 2015-10-23T05:45:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-and-eli-lilly-expand-immuno-oncology-partnership-to-treat-solid-tumours-211015-4700541/ 2015-10-23T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/physicians-interactive-acquires-univadis-231015-4700693/ 2015-10-23T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-advances-second-nav17-inhibitor-for-pain-into-clinical-development-231015-4700741/ 2015-10-23T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/us-national-cancer-institute-awards-grant-to-apogee-for-yeliva-prostate-cancer-research-231015-4700752/ 2015-10-23T08:08:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/imprimis-offers-low-cost-alternative-to-turings-daraprim-drug-231015-4700781/ 2015-10-23T08:43:00+00:00 https://www.pharmaceutical-business-review.com/news/auris-medical-forms-drug-discovery-collaboration-with-kings-college-london-uk-261015-4702011/ 2015-10-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-alexions-strensiq-to-treat-rare-metabolic-disorder-261015-4702044/ 2015-10-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/raumedic-opens-new-building-in-germany-261015-4703382/ 2015-10-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-takes-actions-to-drive-profit-growth-in-2016-and-beyond-261015-4703414/ 2015-10-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/martindale-pharma-extends-distribution-deal-with-aah-pharmaceuticals-261015-4704505/ 2015-10-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgens-imlygic-cancer-drug-recommended-for-approval-in-europe-261015-4701052/ 2015-10-26T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-declines-to-approve-spectrums-evomela-injection-to-treat-multiple-myeloma-261015-4701059/ 2015-10-26T02:02:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-janssens-yondelis-chemotherapy-to-treat-advanced-soft-tissue-sarcomas-261015-4701527/ 2015-10-26T04:55:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/glenmark-signs-deal-with-celon-to-sell-generic-version-of-seretide-accuhaler-in-europe-261015-4701567/ 2015-10-26T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/capsugel-introduces-entrinsic-drug-delivery-technology-platform-261015-4701777/ 2015-10-26T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-announces-3m-milestone-payment-in-duobody-platform-collaboration-with-janssen-261015-4701787/ 2015-10-26T06:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-committee-recommends-approval-of-astrazenecas-lesinurad-to-treat-gout-patients-261015-4701795/ 2015-10-26T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-alpine-immune-sciences-partner-for-cancer-treatment-research-271015-4704541/ 2015-10-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sinovac-dalian-gets-chinese-approval-to-start-human-clinical-trials-of-varicella-vaccine-candidate-271015-4704571/ 2015-10-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biogenes-introduces-improved-generic-ecoli-host-cell-protein-assay-for-biomanufacturing-271015-4703365/ 2015-10-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/coms-interactive-inks-deal-to-incorporate-interact-program-into-daylight-iq-271015-4703718/ 2015-10-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-pharmaceuticals-reviews-accounting-for-its-philidor-arrangement-271015-4703733/ 2015-10-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-crispr-therapeutics-form-gene-editing-collaboration-271015-4702175/ 2015-10-27T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/ipsen-and-epivax-partner-to-create-next-generation-botulinum-neurotoxin-271015-4702338/ 2015-10-27T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-launches-clostridium-difficile-focused-rd-program-271015-4702235/ 2015-10-27T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/mercks-keytruda-lung-cancer-drug-shows-superior-overall-survival-in-phase-23-trial-271015-4702552/ 2015-10-27T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/pra-health-sciences-opens-new-bioanalytical-laboratory-in-assen-netherlands-281015-4704722/ 2015-10-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-and-cytokinetics-heart-failure-drug-succeeds-in-phase-2-trial-281015-4703624/ 2015-10-28T01:48:00+00:00 https://www.pharmaceutical-business-review.com/news/study-finds-withdrawing-dementia-drug-doubles-risk-of-moving-to-nursing-home-281015-4704057/ 2015-10-28T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/trek-therapeutics-starts-phase-2a-clinical-trial-of-td-6450-to-treat-hepatitis-c-281015-4704093/ 2015-10-28T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithklines-losmapimod-cardiovascular-study-fails-281015-4704159/ 2015-10-28T05:04:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/igenica-signs-oncology-research-deal-with-astrazenecas-medimmune-281015-4704564/ 2015-10-28T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-pharmaceuticals-launches-chlorothiazide-sodium-for-injection-usp-281015-4704576/ 2015-10-28T07:52:00+00:00 https://www.pharmaceutical-business-review.com/news/arena-pharmaceuticals-unveils-plans-to-improve-efficiencies-and-reduce-costs-281015-4704581/ 2015-10-28T07:58:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/sri-international-wins-nichd-contract-for-preclinical-development-of-new-contraceptive-products-281015-4704582/ 2015-10-28T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/report-says-global-endoscopy-market-value-will-increase-to-almost-97bn-by-2021-291015-4707078/ 2015-10-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biocision-ucsf-partner-to-advance-cell-therapy-for-organ-transplantation-and-diabetes-291015-4704948/ 2015-10-29T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-us-recalls-auvi-q-allergic-injections-291015-4705083/ 2015-10-29T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-new-indication-for-bristol-myers-yervoy-cancer-drug-291015-4705120/ 2015-10-29T02:33:00+00:00 https://www.pharmaceutical-business-review.com/news/study-finds-gene-targeted-drug-can-treat-prostate-cancer-291015-4705446/ 2015-10-29T05:22:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/probiogen-bio-farma-sign-deal-to-develop-biosimilar-trastuzumab-for-cancer-treatment-291015-4705797/ 2015-10-29T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-submits-new-drug-application-to-fda-for-fixed-dose-combination-of-sofosbuvirvelpatasvir-291015-4705809/ 2015-10-29T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/cevec-biolamina-partner-for-commercial-production-of-recombinant-laminins-for-ex-vivo-cell-therapies-291015-4705824/ 2015-10-29T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uks-mhra-clears-prometics-cta-for-pbi-4050-anti-fibrotic-lead-drug-candidate-291015-4705720/ 2015-10-29T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/intercept-unveils-results-of-phase-2-trial-of-oca-in-nash-patients-in-japan-291015-4705835/ 2015-10-29T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-novartis-new-dual-combination-bronchodilator-utibron-neohaler-to-treat-copd-301015-4706078/ 2015-10-30T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-and-allergan-confirm-merger-talks-301015-4706158/ 2015-10-30T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-starts-phase-2-clinical-trial-of-sgn-cd19a-to-treat-lymphoma-301015-4706239/ 2015-10-30T03:01:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ultragenyx-arcturus-sign-messenger-rna-therapeutics-deal-301015-4706358/ 2015-10-30T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-celgenes-vidaza-as-new-treatment-for-acute-myeloid-leukaemia-301015-4706998/ 2015-10-30T06:38:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-gsk-collaborate-on-pcmm-prototype-for-osd-301015-4707049/ 2015-10-30T06:46:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/globaldata-says-global-treatment-market-for-multiple-myeloma-will-rise-to-224bn-by-2023-301015-4707068/ 2015-10-30T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-wuxi-partner-for-analytical-and-stability-testing-facility-301015-4707102/ 2015-10-30T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/transition-therapeutics-signs-deal-for-phase-2-study-of-tt701-drug-candidate-301015-4707116/ 2015-10-30T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-to-insys-naloxone-sublingual-spray-301015-4707130/ 2015-10-30T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/scientists-investigate-biodegradable-nanomedicine-to-improve-ovarian-cancer-treatments-301015-4707156/ 2015-10-30T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-new-indication-for-eylea-eye-drug-021115-4707447/ 2015-11-02T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-therapy-designation-for-pexidartinib-cancer-drug-021115-4707895/ 2015-11-02T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-starts-phase-2-study-of-isis-fxirx-drug-021115-4707958/ 2015-11-02T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-and-selvita-form-drug-discovery-collaboration-021115-4708007/ 2015-11-02T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/hvivo-invests-in-prep-biopharm-021115-4708293/ 2015-11-02T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-appoints-global-commercial-lead-for-otc-business-021115-4708367/ 2015-11-02T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/allergans-warner-chilcott-pleads-guilty-in-health-care-fraud-scheme-021115-4708397/ 2015-11-02T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/alexza-plans-to-reacquire-us-rights-for-adasuve-loxapine-inhalation-powder-021115-4708416/ 2015-11-02T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-canada-confirms-availability-of-epipen-epinephrine-auto-injector-021115-4708421/ 2015-11-02T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-to-buy-cardioxyl-pharmaceuticals-031115-4708658/ 2015-11-03T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/shire-to-acquire-dyax-for-59bn-031115-4708886/ 2015-11-03T02:13:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-launches-nise-d-pain-relief-spray-in-india-031115-4709237/ 2015-11-03T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-partners-with-biontech-on-cancer-immunotherapies-031115-4709298/ 2015-11-03T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/osiris-therapeutics-launches-truskin-cryopreserved-skin-allograft-031115-4709484/ 2015-11-03T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/organogenesis-receives-marketing-authorization-for-apligraf-wound-healing-technology-in-switzerland-031115-4709507/ 2015-11-03T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-biomed-x-extend-copd-collaboration-031115-4709584/ 2015-11-03T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/conception-kit-at-home-system-launches-product-031115-4709629/ 2015-11-03T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-science-inks-drug-development-deal-with-igxbio-031115-4709644/ 2015-11-03T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharma-acquires-insite-vision-031115-4709661/ 2015-11-03T07:29:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/study-says-people-could-be-risking-health-by-incorrectly-mixing-different-kinds-of-otc-medications-041115-4714702/ 2015-11-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-and-merck-start-phase-i-trial-of-gsk3174998-with-keytruda-041115-4709924/ 2015-11-04T00:22:00+00:00 https://www.pharmaceutical-business-review.com/news/us-ftc-clears-mylans-proposed-acquisition-of-perrigo-041115-4710420/ 2015-11-04T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-starts-phase-ii-trial-of-nsclc-drug-041115-4710513/ 2015-11-04T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/viking-therapeutics-starts-phase-2-trial-of-vk5211-in-hip-fracture-041115-4710601/ 2015-11-04T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/mensia-technologies-secures-funding-to-develop-new-solution-to-treat-adhd-in-children-041115-4710808/ 2015-11-04T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-mimetogen-partner-to-develop-tavilermide-topical-dry-eye-treatment-041115-4710796/ 2015-11-04T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/archerdx-genomoncology-to-partner-on-ngs-workflow-applications-041115-4710824/ 2015-11-04T06:31:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/bristol-myers-squibb-and-johns-hopkins-kimmel-cancer-center-sign-collaboration-deal-041115-4710840/ 2015-11-04T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/tara-immuno-oncology-acquires-licenses-to-develop-clinical-stage-p53mva-oncology-vaccine-041115-4710854/ 2015-11-04T06:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fitnessgenes-introduces-dna-based-fitness-and-nutrition-platform-041115-4710865/ 2015-11-04T06:45:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/dr-reddys-signs-deal-to-market-biocodex-products-in-romania-041115-4710964/ 2015-11-04T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/cognizant-selected-as-technology-partner-for-100000-genomes-project-051115-4714659/ 2015-11-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-glaxosmithklines-nucala-drug-for-severe-asthma-051115-4711187/ 2015-11-05T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-pfizer-start-phase-iii-trial-of-avelumab-drug-in-patients-with-nsclc-051115-4711246/ 2015-11-05T01:34:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-hanmi-sign-diabetes-license-deal-051115-4711805/ 2015-11-05T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/johnson-johnson-to-buy-novira-therapeutics-051115-4711865/ 2015-11-05T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/verona-pharma-completes-patient-enrolment-in-two-rpl554-phase-iia-studies-051115-4711982/ 2015-11-05T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-university-of-washington-start-research-collaboration-051115-4712075/ 2015-11-05T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/nice-recommends-use-of-santens-ikervis-in-england-to-treat-severe-keratitis-051115-4712099/ 2015-11-05T06:31:00+00:00 https://www.pharmaceutical-business-review.com/news/atreca-secures-funding-to-advance-novel-cancer-immunotherapies-pipeline-051115-4712120/ 2015-11-05T06:37:00+00:00 https://www.pharmaceutical-business-review.com/news/clinigen-group-united-therapeutics-start-managed-access-program-for-unituxin-injection-051115-4712141/ 2015-11-05T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/planbox-novatek-partner-for-life-sciences-061115-4714620/ 2015-11-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gilead-sciences-genvoya-hiv-drug-061115-4712573/ 2015-11-06T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-to-review-bristol-myers-application-for-new-indication-for-opdivo-061115-4712800/ 2015-11-06T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/oxigene-unveils-positive-initial-data-from-phase-1b2-study-of-ca4p-drug-061115-4713299/ 2015-11-06T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/taiwanj-gets-fda-nod-to-start-phase-2-study-of-jkb-122-on-autoimmune-hepatitis-061115-4713335/ 2015-11-06T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-lexicon-partner-to-develop-sotagliflozin-oral-medicine-for-diabetes-patients-061115-4713525/ 2015-11-06T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/cytomx-md-anderson-cancer-center-partner-for-probody-enabled-car-nk-cell-therapies-061115-4713549/ 2015-11-06T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/agenus-to-buy-xomas-biologics-manufacturing-facility-061115-4713558/ 2015-11-06T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-gets-fda-warning-letter-for-api-manufacturing-facilities-061115-4713567/ 2015-11-06T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/piramal-enterprises-buys-baby-care-brand-littles-061115-4713573/ 2015-11-06T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/samumed-starts-patient-enrollment-in-sm04690-phase-ii-clinical-trial-091115-4715105/ 2015-11-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/scientists-develop-nanoparticle-delivery-system-for-antibiotic-moxifloxacin-091115-4715113/ 2015-11-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/arkray-usa-wins-contract-from-california-medical-assistance-program091115-4715191/ 2015-11-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cancer-research-uk-lustgarten-foundation-and-stand-up-to-cancer-join-forces-in-pancreatic-cancer-venture-091115-4715787/ 2015-11-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-to-buy-zs-pharma-for-27bn-091115-4713803/ 2015-11-09T00:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ignyta-buys-rights-to-taladegib-oncology-program-from-eli-lilly-091115-4713877/ 2015-11-09T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/hutchison-medipharma-starts-sulfatinib-phase-1-trial-in-us-091115-4714014/ 2015-11-09T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-tentative-approval-to-collegiums-opioid-painkiller-091115-4714563/ 2015-11-09T06:13:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/hanmi-inks-license-agreement-with-janssen-091115-4714742/ 2015-11-09T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-amgens-nda-for-novel-intravenous-calcimimetic-etelcalcetide-091115-4714783/ 2015-11-09T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/german-regulatory-agency-approves-rizaport-to-treat-acute-migraines-101115-4715071/ 2015-11-10T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-to-invest-16m-to-expand-pharmaceutical-development-capacity-101115-4715558/ 2015-11-10T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-avalon-ventures-expand-early-stage-drug-collaboration-101115-4715617/ 2015-11-10T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-immune-pharmaceuticals-ind-for-bertilimumab-to-treat-bullous-pemphigoid-101115-4715671/ 2015-11-10T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/tolero-signs-deal-to-use-eutropics-praedicare-dx-platform-in-alvocidib-clinical-development-101115-4715871/ 2015-11-10T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-new-clinical-protocol-to-evaluate-effects-of-mn-166-on-biomarker-of-als-101115-4715890/ 2015-11-10T06:37:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/harvard-pilgrim-negotiates-fcontract-for-cholesterol-drug-repatha-101115-4716062/ 2015-11-10T08:24:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/huya-bioscience-signs-collaboration-deal-with-techcode-guan-life-sciences-park-101115-4716067/ 2015-11-10T08:31:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/morphotek-signs-license-deal-with-blaze-bioscience-to-develop-novel-oncology-imaging-technology101115-4716075/ 2015-11-10T08:38:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/nicox-fera-pharmaceuticals-partner-to-develop-naproxcinod-in-us-111115-4715936/ 2015-11-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/miragen-secures-financing-to-advance-two-microrna-programs-into-clinical-trials-111115-4715960/ 2015-11-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-to-buy-ocata-therapeutics-111115-4716019/ 2015-11-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/eiger-acquires-license-to-pulmonary-arterial-hypertension-program-from-stanford-university-111115-4716052/ 2015-11-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-genentechs-cotellic-in-combination-with-zelboraf-in-advanced-melanoma-121115-4716567/ 2015-11-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nitrosolution-releases-new-nitroxyl-performance-supplement-121115-4716680/ 2015-11-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-selects-research-partners-for-taneds-collaborative-drug-discovery-project-121115-4717046/ 2015-11-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/stemedica-establishes-stem-cell-manufacturing-facility-in-lausanne-switzerland-121115-4717072/ 2015-11-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/neurogenetic-secures-nia-grant-to-conduct-clinical-trials-with-ngp-555-to-treat-alzheimers-disease-121115-4717084/ 2015-11-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/leo-pharma-to-buy-astellas-pharmas-global-dermatology-portfolio-121115-4716649/ 2015-11-12T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/4d-pharma-secures-approval-for-phase-1-trial-of-crohns-disease-drug-121115-4716733/ 2015-11-12T01:07:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/enterome-gustave-roussy-partner-to-develop-novel-immunotherapy-cancer-treatment-solutions-121115-4717335/ 2015-11-12T05:13:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/recipharm-signs-25m-api-contract-extension-with-daewoong-pharmaceutical-121115-4717400/ 2015-11-12T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/wuxi-nextcode-selected-as-clinical-interpretation-partner-for-100000-genomes-project-121115-4717611/ 2015-11-12T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/essential-pharmaceuticals-releases-cell-ess-media-supplement-for-proteins-and-vaccines-bioproduction-121115-4717665/ 2015-11-12T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-submits-prior-approval-supplement-for-restasis-005-mdpf-bottle-121115-4717694/ 2015-11-12T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/immune-design-starts-phase-2-cancer-immunotherapy-combination-trial-isoft-tissue-sarcoma-patients-121115-4717711/ 2015-11-12T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/amplyx-secures-405m-in-series-b-financing-to-support-clinical-development-of-apx001-121115-4717719/ 2015-11-12T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/abcam-to-buyamerican-antibody-technology-firm-axiomx-121115-4717757/ 2015-11-12T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gilead-sciences-harvoni-hepatitis-c-drug-for-expanded-use-131115-4718029/ 2015-11-13T00:25:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-to-invest-11bn-for-medical-rd-131115-4718159/ 2015-11-13T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/scynexis-starts-phase-1-study-to-evaluate-intravenous-formulation-of-scy-078-131115-4718829/ 2015-11-13T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/researchers-to-launch-multinational-precision-medicine-trial-for-deadliest-brain-tumor-131115-4718911/ 2015-11-13T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-baxaltas-obizur-haemophilia-a-drug-131115-4719040/ 2015-11-13T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/repros-completes-randomization-of-phase-2b-study-of-vaginal-proellex-in-women-with-symptomatic-uterine-fibroids-131115-4719070/ 2015-11-13T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/dbv-technologies-enrolls-first-patient-in-phase-iia-study-in-pediatric-eosinophilic-esophagitis-131115-4719090/ 2015-11-13T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/retrosense-secures-financing-to-advance-clinical-development-of-rst-001-for-retinitis-pigmentosa-131115-4719132/ 2015-11-13T07:32:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/beckman-coulter-incelldx-sign-distribution-deal-for-human-papilloma-virus-research-131115-4719147/ 2015-11-13T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/targazyme-umcc-to-advance-development-of-tz101-for-use-with-regulatory-t-cells-131115-4719163/ 2015-11-13T07:54:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/immunocellular-signs-sponsored-research-deal-with-university-of-texas-md-anderson-cancer-131115-4719171/ 2015-11-13T07:59:00+00:00 https://www.pharmaceutical-business-review.com/news/meridian-bioscience-makes-minority-investment-in-oasis-diagnostics-131115-4719179/ 2015-11-13T08:06:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/elusys-therapeutics-wins-delivery-order-in-us-for-anthim-to-treat-inhalational-anthrax-131115-4719183/ 2015-11-13T08:11:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-wins-us-approval-for-tagrisso-lung-cancer-drug-161115-4719447/ 2015-11-16T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/swissmedic-approves-xadago-to-treat-parkinsons-disease-161115-4719584/ 2015-11-16T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/charles-river-laboratories-launches-endosafe-nexgen-pts-161115-4720057/ 2015-11-16T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/abbvie-submits-imbruvica-phase-iii-combination-data-to-fda-161115-4720130/ 2015-11-16T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-shareholders-reject-mylans-26bn-takeover-bid-161115-4720435/ 2015-11-16T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-arch-biopartners-ab569-161115-4720470/ 2015-11-16T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/auris-medical-enrolls-first-patient-in-healos-study-of-am-111-161115-4720477/ 2015-11-16T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/epic-sciences-partners-with-university-of-pennsylvanias-abramson-cancer-center-on-cancer-therapy-discoveries-161115-4720498/ 2015-11-16T07:50:00+00:00 https://www.pharmaceutical-business-review.com/news/auven-therapeutics-unveils-positive-results-from-clinical-trial-of-seciera-in-dry-eye-disease-161115-4720504/ 2015-11-16T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-janssen-biotechs-darzalex-drug-to-treat-multiple-myeloma-171115-4728600/ 2015-11-17T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/emerson-ge-healthcare-partner-to-increase-biopharma-manufacturing-efficiency-171115-4729170/ 2015-11-17T04:39:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/array-biopharma-pierre-fabre-partner-to-develop-two-novel-oncology-products-171115-4729229/ 2015-11-17T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-orphan-drug-designation-to-retrophins-sparsentan-to-treat-fsgs-171115-4729271/ 2015-11-17T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-halts-production-at-softgel-plant-in-beinheim-france-171115-4729594/ 2015-11-17T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-bristol-myers-squibbs-sbla-for-opdivo-in-advanced-renal-cell-carcinoma-171115-4729602/ 2015-11-17T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/gileads-zydelig-shows-superior-efficacy-to-bendamustinerituximab-in-phase-3-study-171115-4729617/ 2015-11-17T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/turing-starts-dosing-in-phase-i-clinical-study-of-tur-004-for-epileptic-encephalopathies-171115-4729623/ 2015-11-17T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-launches-generic-viramune-xr-extended-release-tablets-in-us-171115-4729630/ 2015-11-17T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-to-exercise-fovista-rights-under-novartis-agreement-181115-4730003/ 2015-11-18T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/summit-therapeutics-oxford-university-extend-alliance-to-develop-utrophin-modulators-for-dmd-181115-4730180/ 2015-11-18T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/cerulean-astrazeneca-and-nci-collaborate-on-cancer-combination-study-181115-4730494/ 2015-11-18T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-court-upholds-helsinn-healthcares-patents-on-aloxi-antinausea-drug-181115-4730581/ 2015-11-18T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-expanded-use-of-vertexs-kalydeco-drug-to-treat-cystic-fibrosis-181115-4731003/ 2015-11-18T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-enhances-clinical-development-services-181115-4731013/ 2015-11-18T07:38:00+00:00 https://www.pharmaceutical-business-review.com/news/immune-pharmaceuticals-enrolls-first-patient-in-phase-2-clinical-trial-with-bertilimumab-181115-4731021/ 2015-11-18T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/infinity-completes-target-enrollment-in-phase-3-study-evaluating-duvelisib-in-chronic-lymphocytic-leukemia-181115-4731030/ 2015-11-18T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/lgc-acquires-maine-standards-company-181115-4731034/ 2015-11-18T07:50:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/fda-takes-action-to-protect-consumers-from-potential-dangerous-dietary-supplements-181115-4731044/ 2015-11-18T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-agrees-to-acquire-us-and-canadian-rights-to-cebranopadol-from-grnenthal-181115-4731061/ 2015-11-18T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/morphotek-university-of-gothernburg-partner-to-develop-farletuzumab-for-alpha-particle-radioimmunotherapy-in-ovarian-cancer-181115-4731072/ 2015-11-18T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-breakthrough-status-for-avelumab-skin-cancer-drug-191115-4731396/ 2015-11-19T00:31:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/mundipharma-buys-certain-rights-to-sell-zevalin-from-spectrum-pharmaceuticals-191115-4731467/ 2015-11-19T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-sandozs-filing-for-biosimilar-to-amgens-neulasta-cancer-drug-191115-4731540/ 2015-11-19T02:55:00+00:00 https://www.pharmaceutical-business-review.com/news/rebiotix-completes-patient-enrollment-to-evaluate-rbx2660-microbiota-restoration-therapy-191115-4732013/ 2015-11-19T05:16:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/turing-pharmaceuticals-inks-research-deal-with-university-of-toledo-for-canavan-disease-191115-4732337/ 2015-11-19T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/crown-bioscience-offers-immuno-oncology-translational-research-platform-191115-4732350/ 2015-11-19T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-receives-crl-from-fda-for-single-dose-preservative-free-vial-of-makena-191115-4732360/ 2015-11-19T07:06:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ipsen-interprotein-partner-to-develop-new-therapeutic-peptides-in-endocrinology-191115-4732329/ 2015-11-19T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-starts-clinical-trial-with-accurin-azd2811-in-solid-tumors-191115-4732425/ 2015-11-19T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/aduro-receives-payment-from-janssen-for-ind-application-submission-for-adu-741-in-prostate-cancer191115-4732431/ 2015-11-19T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/onxeo-starts-strategy-to-explore-further-potential-indications-for-livatag-and-beleodaq-drugs-191115-4732439/ 2015-11-19T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-university-college-london-start-brain-imaging-study-to-treat-neurodegenerative-diseases-201115-4732785/ 2015-11-20T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-adapt-pharmas-narcan-nasal-spray-to-treat-opioid-overdose-201115-4733280/ 2015-11-20T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-amgens-kyprolis-for-combination-use-to-treat-relapsed-multiple-myeloma-201115-4732869/ 2015-11-20T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/servier-exercises-option-to-buy-rights-to-cellectis-ucart19-immunotherapy-candidate-201115-4733361/ 2015-11-20T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/lilly-merck-extend-immuno-oncology-collaboration-201115-4733595/ 2015-11-20T06:55:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/prometic-inks-deals-with-prothera-to-develop-plasma-derived-inter-alpha-inhibitor-proteins-201115-4733619/ 2015-11-20T07:02:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ampliphi-signs-deal-with-australian-university-to-conduct-phase-i-trial-of-bacteriophage-therapy-201115-4733631/ 2015-11-20T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/portages-biohaven-says-phase-1-pharmacokinetic-study-meets-study-objectives-201115-4733651/ 2015-11-20T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/spring-bank-partners-with-gilead-sciences-for-hepatitis-b-phase-2-clinical-trial-201115-4733667/ 2015-11-20T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/remd-biotherapeutics-enrolls-patients-in-phase-2-trial-of-remd-477-in-type-2-diabetes-201115-4733677/ 2015-11-20T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/m-pharmaceutical-signs-loi-to-buy-reformulated-orlistat-for-weight-loss-from-chelatexx-231115-4735711/ 2015-11-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/baxalta-submits-cta-to-uk-mhra-for-bax-826-trial-in-haemophilia-a-231115-4733963/ 2015-11-23T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-seeks-us-approval-for-extended-release-formulation-of-invokamet-for-type-2-diabetes-231115-4734165/ 2015-11-23T03:10:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/chmp-recommends-samsung-bioepis-enbrel-biosimilar-for-eu-approval-231115-4734448/ 2015-11-23T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-to-pay-390m-to-settle-us-civil-fraud-lawsuit-231115-4734545/ 2015-11-23T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-marketing-authorisation-for-vertexs-orkambi-cystic-fibrosis-drug-231115-4734739/ 2015-11-23T07:55:00+00:00 https://www.pharmaceutical-business-review.com/news/kadmon-inks-deal-with-jinghua-to-develop-antibody-product-candidates-in-china-231115-4734741/ 2015-11-23T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/uk-and-bill-gates-launch-1bn-fund-to-tackle-malaria-231115-4734691/ 2015-11-23T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-ninlaro-oral-medication-to-treat-multiple-myeloma-231115-4734747/ 2015-11-23T08:07:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/idera-gsk-to-collaborate-on-third-generation-antisense-molecules-to-treat-renal-disease-241115-4736066/ 2015-11-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-allergan-agree-160bn-merger-241115-4735145/ 2015-11-24T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/pershing-square-increases-stake-in-valeant-pharmaceuticals-241115-4735554/ 2015-11-24T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-agrees-to-sell-us-rights-for-entocort-drug-to-perrigo-241115-4735626/ 2015-11-24T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-marketing-authorisation-to-gileads-genvoya-for-hiv-1-infection-241115-4735668/ 2015-11-24T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-pradaxa-for-prophylaxis-of-deep-venous-thrombosis-and-pulmonary-embolism-241115-4736031/ 2015-11-24T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/lsp-bristol-myers-squibb-partner-to-work-on-immuno-oncology-innovation-in-europe-241115-4736015/ 2015-11-24T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/samumed-completes-phase-ii-study-for-potential-treatment-of-androgenetic-alopecia-241115-4736042/ 2015-11-24T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/arsanis-starts-phase-1-study-of-lead-product-candidate-asn100-241115-4736051/ 2015-11-24T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/european-commission-approves-novartis-entresto-heart-failure-drug-251115-4736399/ 2015-11-25T01:36:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/brickell-biotech-secures-rights-to-ror-inhibitors-for-psoriasis-251115-4736471/ 2015-11-25T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-gets-expansion-approval-for-volibris-drug-in-europe-251115-4736572/ 2015-11-25T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-declines-to-approve-indiviors-naloxone-nasal-spray-for-opioid-overdose-251115-4736931/ 2015-11-25T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/xellia-pharmaceuticals-acquires-hikmas-ohio-manufacturing-plants-251115-4737265/ 2015-11-25T07:26:00+00:00 https://www.pharmaceutical-business-review.com/news/green-cross-submits-biologics-license-application-to-fda-for-ivig-sn-251115-4737367/ 2015-11-25T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/adaptimmune-starts-phase-i-ii-study-evaluating-affinity-enhanced-t-cell-therapy-251115-4737381/ 2015-11-25T07:35:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/orgenesis-biosequel-partner-to-conduct-clinical-trials-for-type-1-diabetes-in-russia-251115-4737413/ 2015-11-25T07:57:00+00:00 https://www.pharmaceutical-business-review.com/news/allergan-collaborates-with-rugen-therapeutics-to-develop-asd-and-ocd-therapies-261115-4737675/ 2015-11-26T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-begins-dosing-in-phase-iii-study-of-sirukumab-for-treatment-of-giant-cell-arteritis-261115-4737773/ 2015-11-26T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-expanded-label-for-pfizers-xalkori-nsclc-drug-261115-4738176/ 2015-11-26T05:05:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/teva-signs-licensing-deal-with-heptares-therapeutics-for-migraine-treatments-261115-4738234/ 2015-11-26T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-cotelliczelboraf-combination-to-treat-advanced-melanoma-261115-4738428/ 2015-11-26T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-submits-bla-to-fda-for-abp-501-261115-4738436/ 2015-11-26T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-wins-european-approval-for-numient-to-treat-parkinsons-disease-261115-4738454/ 2015-11-26T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/aaipharmacambridge-major-laboratories-to-invest-15m-for-laboratories-expansion-261115-4738462/ 2015-11-26T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-seqirus-fluad-for-adults-aged-65-years-and-older-against-seasonal-influenza-261115-4738474/ 2015-11-26T07:34:00+00:00 https://www.pharmaceutical-business-review.com/news/sinclair-is-pharma-to-sell-non-aesthetics-business-to-alliance-pharma-271115-4738775/ 2015-11-27T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-approves-boehringer-ingelheims-praxbind-anticoagulant-reversal-agent-271115-4739157/ 2015-11-27T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/hvivo-raises-205m-to-support-portfolio-development-271115-4739181/ 2015-11-27T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/lightpoint-medical-receives-grant-to-carry-out-breast-cancer-clinical-trial-271115-4739359/ 2015-11-27T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/solasia-lees-pharma-sign-license-agreement-for-sancuso-271115-4739361/ 2015-11-27T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/childrens-cancer-death-rates-drop-by-24-in-last-decade-271115-4739399/ 2015-11-27T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/accutest-fox-chase-cancer-center-partner-on-clinical-trials-for-oncology-271115-4739409/ 2015-11-27T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/bioasis-technologies-secures-us-patent-for-delivery-of-therapeutic-agents-301115-4740507/ 2015-11-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/royal-philips-launches-advanced-imaging-data-sharing-analytics-and-visualization-platform-301115-4740517/ 2015-11-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-siemens-multitom-rax-robotic-x-ray-system-301115-4740540/ 2015-11-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/cell-therapy-catapult-signs-mou-with-kanagawa-prefecture-japan-301115-4740559/ 2015-11-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/samsung-biologics-to-invest-736m-to-build-new-drug-manufacturing-plant-in-south-korea-301115-4739626/ 2015-11-30T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-declines-to-approve-expanded-use-of-bristol-myers-squibbs-opdivo-drug-301115-4740000/ 2015-11-30T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/lannett-acquires-kremers-urban-pharmaceuticals-for-123bn-301115-4740044/ 2015-11-30T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/european-medicines-agency-accepts-to-review-helsinns-maa-for-anamorelin-hci-301115-4740080/ 2015-11-30T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/heptares-therapeutics-pfizer-partner-for-gpcr-focused-drug-discovery-011215-4740716/ 2015-12-01T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-pharma-gets-european-approval-for-ravicti-to-treat-urea-cycle-disorders-011215-4741073/ 2015-12-01T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/capgenesis-submits-orphan-drug-designation-requests-in-us-and-europe-for-cgs-200-011215-4741133/ 2015-12-01T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-seeks-approval-of-stelara-for-crohns-disease-011215-4741187/ 2015-12-01T05:11:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/roche-upsher-smith-laboratories-sign-license-deal-to-develop-novel-vap-1-inhibitor-011215-4741247/ 2015-12-01T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-empliciti-to-treat-multiple-myeloma-011215-4741273/ 2015-12-01T05:43:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-takeda-partner-to-establish-new-business-venture-in-japan-011215-4741292/ 2015-12-01T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/pieris-achieves-third-payment-milestone-in-rd-collaboration-with-sanofi-011215-4741310/ 2015-12-01T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-biopharma-completes-dosing-in-phase-iia-study-of-rhb-104-for-multiple-sclerosis-011215-4741323/ 2015-12-01T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/biolight-partners-with-axella-research-for-celldetect-non-invasive-diagnostic-test-011215-4741345/ 2015-12-01T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/us-researchers-re-engineer-crispr-cas9-system-to-minimize-gene-editing-errors-021215-4741889/ 2015-12-02T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-gets-rare-pediatric-disease-designation-for-kevetrin-to-treat-retinoblastoma-021215-4742179/ 2015-12-02T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-arena-complete-patient-enrollment-in-belviq-camellia-timi-61-study-021215-4742246/ 2015-12-02T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/cardiocell-plans-phase-iib-clinical-trial-using-stem-cells-for-chronic-heart-failure-021215-4742716/ 2015-12-02T07:32:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/immunocellular-inks-deal-with-eortc-for-ict-107-phase-3-registrational-trial-in-glioblastoma-021215-4742727/ 2015-12-02T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/mabvax-therapeutics-files-ind-for-phase-i-clinical-trial-with-humab-5b1-021215-4742733/ 2015-12-02T07:40:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-introduces-impact-express-clinical-trial-management-system-021215-4742739/ 2015-12-02T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/biovicas-divitum-technology-selected-for-new-cancer-drug-trial-021215-4742746/ 2015-12-02T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/neurona-therapeutics-launches-with-235m-financing-to-repair-damaged-neural-circuits-021215-4742760/ 2015-12-02T08:00:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-abbvies-viekira-pak-formulation-to-treat-chronic-hepatitis-c-031215-4743072/ 2015-12-03T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/oric-pharmaceuticals-raises-53m-to-advance-prostate-cancer-drug-development-031215-4743611/ 2015-12-03T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-places-zafgens-beloranib-ind-on-hold-after-second-patient-death-031215-4743661/ 2015-12-03T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/scripps-florida-scientists-create-fingerprints-for-major-drug-development-targets-031215-4743824/ 2015-12-03T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/altheadx-introduces-new-ngs-oncology-panel-for-drug-development-programs-031215-4743837/ 2015-12-03T05:59:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/boehringer-ingelheim-md-anderson-cancer-center-partner-to-discover-new-medicines-for-pancreatic-cancer-031215-4743864/ 2015-12-03T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-secures-european-marketing-authorisation-for-nucala-in-31-countries-031215-4743882/ 2015-12-03T06:11:00+00:00 https://www.pharmaceutical-business-review.com/news/cynvenio-biosystems-partners-with-university-of-southern-denmark-for-cancer-clinical-trials-031215-4743899/ 2015-12-03T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/summit-achieves-first-milestone-in-alliance-with-university-of-oxford-4743918/ 2015-12-03T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/study-finds-antidepressant-medication-protects-against-blood-compounds-linked-to-dementia-031215-4743940/ 2015-12-03T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-therapeutics-partners-with-fukushima-medical-university-to-test-radiation-therapy-041215-4744532/ 2015-12-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/zymeworks-gsk-sign-antibody-collaboration-deal-041215-4744486/ 2015-12-04T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/clinigen-partners-with-sunesis-to-start-compassionate-use-program-for-vosaroxin-041215-4744545/ 2015-12-04T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-to-trevenas-oliceridine-041215-4744556/ 2015-12-04T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/invivo-secures-conditional-approval-for-inspire-probable-benefit-clinical-study-041215-4744567/ 2015-12-04T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/morphotek-wisconsin-university-to-study-immunosuppressive-effects-of-ca125-tumor-antigen-041215-4744582/ 2015-12-04T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/redx-pharma-identifies-new-cancer-drug-development-candidate-041215-4744533/ 2015-12-04T02:26:00+00:00 https://www.pharmaceutical-business-review.com/news/tocagen-enrolls-first-patient-in-phase-23-clinical-trial-in-patients-with-recurrent-glioblastoma-041215-4745294/ 2015-12-04T06:42:00+00:00 https://www.pharmaceutical-business-review.com/news/acorda-starts-phase-1-clinical-trial-of-cvt-427-for-acute-treatment-of-migraines-041215-4745304/ 2015-12-04T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-merck-collaborate-for-two-cancer-immunotherapy-trials-071215-4745667/ 2015-12-07T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-to-review-gileads-maa-for-chronic-hcv-single-tablet-regimen-071215-4746170/ 2015-12-07T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-halts-development-of-potential-diabetes-treatment-071215-4746229/ 2015-12-07T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/adc-therapeutics-wins-fda-nod-to-start-clinical-studies-for-adct-402-antibody-drug-conjugate-071215-4746415/ 2015-12-07T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-validates-radius-healths-maa-for-abaloparatide-sc-to-treat-osteoporosis-in-postmenopausal-women-071215-4746535/ 2015-12-07T07:08:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-pkc412-drug-improves-overall-survival-by-23-in-phase-iii-study-071215-4746554/ 2015-12-07T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/bials-zebinix-meets-primary-endpoint-in-phase-3-study-for-patients-with-newly-diagnosed-partial-onset-seizures-071215-4746577/ 2015-12-07T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-astrazeneca-start-fusion-clinical-development-program-in-immuno-oncology-081215-4746834/ 2015-12-08T00:12:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-halts-cancer-drug-development-after-trials-fail-081215-4747430/ 2015-12-08T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/erytech-raises-254m-in-financing-for-clinical-and-preclinical-programs-081215-4747490/ 2015-12-08T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/vanc-pharmaceuticals-launches-first-otc-product-in-british-columbia-081215-4747680/ 2015-12-08T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/kite-pharma-receives-fda-breakthrough-therapy-designation-for-kte-c19-081215-4747699/ 2015-12-08T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-starts-phase-3-trial-of-iclusig-in-second-line-patients-with-cml-in-chronic-phase-081215-4747712/ 2015-12-08T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/allergy-therapeutics-enrolls-first-ten-us-patients-in-grassmatampl-204-phase-ii-study-081215-4747731/ 2015-12-08T06:26:00+00:00 https://www.pharmaceutical-business-review.com/news/bioatla-signs-deal-with-pfizer-to-co-develop-new-antibody-therapeutics-091215-4748185/ 2015-12-09T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-sandozs-maa-for-biosimilar-to-pfizers-enbrel-drug-091215-4748862/ 2015-12-09T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-alexions-kanuma-to-treat-lysosomal-acid-lipase-deficiency-091215-4748920/ 2015-12-09T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/panacea-secures-15m-financing-for-phase-1-clinical-study-of-cancer-immunotherapeutic-drug-091215-4749305/ 2015-12-09T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/adimab-forms-antibody-discovery-collaborations-with-md-anderson-and-memorial-sloan-kettering-091215-4749320/ 2015-12-09T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/celldex-starts-phase-12-study-of-varlilumab-in-combination-with-atezolizumab-in-rcc-091215-4749329/ 2015-12-09T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-establishes-center-for-molecular-synthesis-in-collaboration-with-princeton-university-091215-4749343/ 2015-12-09T07:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ignyta-starts-startrk-ng-phase-11b-pediatric-clinical-trial-of-entrectinib-101215-4750961/ 2015-12-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/constellation-pharmaceuticals-raises-55m-in-mezzanine-financing-101215-4750990/ 2015-12-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mexico-approves-worlds-first-dengue-vaccine-101215-4751068/ 2015-12-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-merck-start-two-phase-iii-clinical-trials-of-avelumab-in-gastric-cancers-101215-4749674/ 2015-12-10T01:43:00+00:00 https://www.pharmaceutical-business-review.com/news/allena-raises-53m-to-advance-alln-177-into-phase-3-clinical-studies-101215-4749745/ 2015-12-10T01:50:00+00:00 https://www.pharmaceutical-business-review.com/news/armgo-wins-two-fda-designations-for-arm210-to-treat-duchenne-muscular-dystrophy-101215-4749937/ 2015-12-10T02:31:00+00:00 https://www.pharmaceutical-business-review.com/news/catabasis-doses-first-patient-in-phase-2a-trial-of-cat-2054-to-treat-hypercholesterolemia-101215-4750659/ 2015-12-10T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-ocular-therapeutixs-nda-for-dextenza-101215-4750679/ 2015-12-10T07:18:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/globaldata-analyst-says-pharma-outsourcing-mergers-and-acquisitions-set-for-record-year-in-2015-111215-4751085/ 2015-12-10T23:43:00+00:00 https://www.pharmaceutical-business-review.com/news/biothera-plans-to-evaluate-combination-therapy-of-imprime-pgg-and-mercks-keytruda-111215-4751004/ 2015-12-10T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/syncona-uclb-launch-freeline-therapeutics-to-develop-gene-therapies-for-bleeding-disorders-111215-4751014/ 2015-12-10T23:44:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-recommends-approval-of-tevas-reslizumab-asthma-drug-for-adults-111215-4751020/ 2015-12-10T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-for-nusirt-biopharmas-non-alcoholic-fatty-liver-disease-treatment-111215-4751423/ 2015-12-11T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/theravance-biopharma-doses-first-subject-in-phase-1-clinical-trial-of-td-1473-111215-4751443/ 2015-12-11T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-pfizers-ibrance-supplemental-new-drug-application-111215-4751464/ 2015-12-11T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/argos-independent-data-monitoring-committee-recommends-continuation-of-ags-003-phase-3-clinical-trial-111215-4751470/ 2015-12-11T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/kadimastem-inks-deals-with-fda-for-framework-of-clinical-trials-in-humans-to-treat-als-111215-4751482/ 2015-12-11T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-wellstats-vistogard-for-chemotherapy-overdose-141215-4751842/ 2015-12-14T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-starts-phase-12-clinical-study-of-isis-sod1-rx-in-als-patients-141215-4752007/ 2015-12-14T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/australian-court-rules-reckitt-benckiser-misled-consumers-on-nurofen-painkillers-141215-4752373/ 2015-12-14T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-collaborates-with-wallenberg-centre-for-protein-research-141215-4752626/ 2015-12-14T06:45:00+00:00 https://www.pharmaceutical-business-review.com/news/cytomx-selects-second-clinical-candidate-from-probody-therapeutic-pipeline-141215-4752689/ 2015-12-14T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/xbiotech-announces-agreement-with-the-ncic-clinical-trials-group-to-collaborate-on-phase-ii-study-in-non-small-cell-lung-cancer-nsclc-4752704/ 2015-12-14T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-accelerated-approval-to-alecensa-for-people-with-specific-type-of-lung-cancer-141215-4752713/ 2015-12-14T07:20:00+00:00 https://www.pharmaceutical-business-review.com/news/lz-lifescience-unveils-manufacturing-execution-system-for-pharma-sector-141215-4752744/ 2015-12-14T07:38:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/amgen-reacquires-rights-to-three-drugs-from-gsk-in-48-countries-151215-4753004/ 2015-12-15T00:28:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ucla-bristol-myers-squibb-join-hands-for-immuno-oncology-research-151215-4753174/ 2015-12-15T03:10:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-considering-acerta-pharma-bid-to-acquire-blood-cancer-drug-151215-4753335/ 2015-12-15T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-nephrogenexs-ind-application-for-clinical-study-of-intravenous-pyridorin-to-treat-acute-kidney-injury151215-4753838/ 2015-12-15T05:51:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/immunocellular-inks-deal-with-cbtc-for-ict-107-phase-3-registrational-trial-in-glioblastoma-151215-4753854/ 2015-12-15T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-starts-phase-12-clinical-trial-of-intra-tumoral-imo-2125-in-combination-with-ipilimumab-151215-4753870/ 2015-12-15T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-zogenixs-ind-application-for-zx008-phase-3-clinical-trial-in-dravet-syndrome-151215-4753890/ 2015-12-15T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/bind-to-advance-squamous-histology-nsclc-cohort-to-second-stage-of-insite-1-trial-151215-4753918/ 2015-12-15T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-qidp-designation-to-matinas-antibacterial-development-candidate-mat2501-151215-4753940/ 2015-12-15T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-completes-enrollment-of-phase-3-trial-of-rsv-f-vaccine-in-older-adults-151215-4754027/ 2015-12-15T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/pharnext-starts-pleo-cmt-phase-3-trial-in-charcot-marie-tooth-disease-type-1a-161215-4755833/ 2015-12-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-spero-therapeutics-expand-collaboration-to-develop-novel-antibacterials-161215-4755846/ 2015-12-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-boehringer-ingelheim-in-negotiations-for-asset-swap-161215-4754396/ 2015-12-16T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-expanded-age-indication-for-mercks-gardasil-9-in-males-161215-4755039/ 2015-12-16T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/braeburn-camurus-enroll-first-patient-in-phase-3-trial-of-cam2038-for-opioid-dependence-161215-4755068/ 2015-12-16T05:07:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astrazeneca-completes-deal-with-perrigo-for-rights-to-entocort-in-us-161215-4755477/ 2015-12-16T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/kitov-pharmaceuticals-phase-iii-trial-meets-primary-efficacy-endpoint-161215-4755482/ 2015-12-16T07:39:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-strengthens-chinese-operations-and-respiratory-business-with-new-deals-171215-4755794/ 2015-12-17T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-status-for-paxvaxs-vaxchora-cholera-vaccine-171215-4756343/ 2015-12-17T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-basaglar-diabetes-drug-171215-4756405/ 2015-12-17T04:57:00+00:00 https://www.pharmaceutical-business-review.com/news/arsia-therapeutics-biogen-sign-research-collaboration-to-develop-subcutaneous-biologics-171215-4756846/ 2015-12-17T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/array-biopharmas-phase-3-binimetinib-trial-meets-primary-endpoint-for-nras-mutant-melanoma-171215-4756853/ 2015-12-17T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/stem-cell-theranostics-capellabio-establish-cardio-oncology-collaboration-171215-4756860/ 2015-12-17T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/biopharmaceutical-firm-ucb-implements-sinequa-big-data-search-analytics-platform-171215-4756870/ 2015-12-17T07:29:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/spectrum-inks-deal-with-fda-on-special-protocol-assessment-for-spi-2012-registrational-trial-171215-4756875/ 2015-12-17T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-gilead-join-hands-to-develop-filgotinib-inflammatory-drug-181215-4757226/ 2015-12-18T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-to-buy-55-stake-in-acerta-pharma-for-4bn-181215-4757353/ 2015-12-18T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/us-sec-charges-turing-pharmaceuticals-ceo-on-securities-fraud-181215-4757886/ 2015-12-18T05:25:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-to-buy-retin-a-portfolio-from-matawan-pharmaceuticals-181215-4758160/ 2015-12-18T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/tetragenetics-launches-partnership-program-to-develop-therapeutic-monoclonal-antibodies-181215-4758175/ 2015-12-18T07:16:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/xl-protein-easton-sign-license-deal-to-develop-biopharmaceuticals-using-pasylation-technology-181215-4758191/ 2015-12-18T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/catalyst-completes-nda-submission-to-fda-for-firdapse-to-treat-lems-and-cms-181215-4758202/ 2015-12-18T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/mirati-doses-first-patient-in-expansion-cohorts-of-mgcd516-phase-1b-trial-181215-4758207/ 2015-12-18T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-acquire-bristol-myers-squibbs-hiv-assets-211215-4758680/ 2015-12-21T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/chmp-issues-positive-opinions-for-astrazenecas-three-marketing-applications-211215-4759014/ 2015-12-21T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-bavarian-nordic-partner-to-develop-hpv-vaccine-211215-4759056/ 2015-12-21T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-expanded-indication-for-mercks-keytruda-tom-treat-advanced-melanoma-211215-4759454/ 2015-12-21T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/scancell-forms-us-investigator-team-to-lead-phase-ii-checkpoint-inhibitor-combination-study-with-scib1-211215-4759469/ 2015-12-21T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/midatech-agrees-to-acquire-zuplenz-marketed-oncology-product-from-galena-biopharma-211215-4759480/ 2015-12-21T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/aaipharma-servicescambridge-major-laboratories-upgrade-small-molecule-manufacturing-capabilities-at-weert-site-211215-4759486/ 2015-12-21T07:48:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-crispr-to-create-jv-to-develop-new-gene-therapies-221215-4759719/ 2015-12-22T01:51:00+00:00 https://www.pharmaceutical-business-review.com/news/samsung-breaks-ground-on-third-biopharmaceutical-manufacturing-plant-in-south-korea-221215-4759747/ 2015-12-22T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-ingelheim-selects-medidata-technology-platform-for-drug-development-innovation-221215-4759889/ 2015-12-22T03:00:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/gsk-sells-rights-to-ofatumumab-for-auto-immune-indications-to-novartis-221215-4760762/ 2015-12-22T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-completes-ccp-07-single-dose-comparative-bioavailability-study-221215-4760775/ 2015-12-22T07:13:00+00:00 https://www.pharmaceutical-business-review.com/news/abivax-completes-patient-enrollment-in-abx464-phase-iia-hiv-study-221215-4760787/ 2015-12-22T07:18:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/aveo-eusa-pharma-sign-licensing-deal-for-tivozanib-in-europe-221215-4760800/ 2015-12-22T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/emulate-merck-expand-collaboration-to-use-organ-chips-in-drug-discovery-process-for-inflammatory-diseases-221215-4760822/ 2015-12-22T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-merck-start-two-new-trails-of-avelumab-in-ovarian-and-urothelial-cancers-231215-4761180/ 2015-12-23T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/intrexon-janssen-pharmaceutica-partner-to-develop-therapies-for-type-2-diabetes-231215-4761313/ 2015-12-23T02:19:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-submits-maa-to-ema-for-rviii-singlechain-for-patients-with-hemophilia-a-231215-4762057/ 2015-12-23T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-accepts-vandas-fanaptum-maa-to-treat-schizophrenia-in-adults-231215-4762062/ 2015-12-23T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-amends-mm-121-phase-2-clinical-study-in-heregulin-positive-nsclc-231215-4762067/ 2015-12-23T07:36:00+00:00 https://www.pharmaceutical-business-review.com/news/nemus-signs-research-deal-with-university-of-mississippi-to-develop-cannabinoid-based-therapies-for-cipn-231215-4762073/ 2015-12-23T07:40:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/forge-therapeutics-secures-license-for-intellectual-property-on-metalloprotein-inhibitors-231215-4762078/ 2015-12-23T07:45:00+00:00 https://www.pharmaceutical-business-review.com/news/hemostemix-plans-to-expand-phase-2-clinical-trial-of-acp-01-to-us-231215-4762087/ 2015-12-23T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-and-bristol-myers-squibb-start-new-trial-assessing-combination-of-adcetris-and-opdivo-241215-4762255/ 2015-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/helix-biopharma-opens-patient-screening-for-new-cohort-in-poland-241215-4762351/ 2015-12-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tonix-enrolls-patients-for-phase-2-atease-clinical-trial-241215-4762297/ 2015-12-24T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/selecta-biosciences-announces-dosing-of-first-patient-in-phase-1b-clinical-trial-of-sel-212-241215-4762374/ 2015-12-24T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-files-first-clinical-trial-application-for-ucart19-241215-4762382/ 2015-12-24T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/agenus-acquires-phosimmune-with-novel-class-of-cancer-neoantigens-241215-4762393/ 2015-12-24T02:18:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/ncku-duke-collaborate-to-better-design-ventricular-assist-device-241215-4762400/ 2015-12-24T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-gbt440-to-treat-sickle-cell-disease-040116-4766214/ 2016-01-04T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-gets-fda-orphan-drug-designation-for-plx-pad-cells-to-treat-severe-preeclampsia-040116-4766542/ 2016-01-04T04:53:00+00:00 https://www.pharmaceutical-business-review.com/news/acerus-pharmaceuticals-terminates-natesto-deal-with-endo-040116-4766562/ 2016-01-04T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/araim-partners-with-vault-bioventures-to-support-development-of-ara-290-and-other-peptides-040116-4766579/ 2016-01-04T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/vivus-unveils-intent-to-reacquire-us-and-canadian-rights-for-stendra-040116-4766587/ 2016-01-04T05:10:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/lixte-licenses-lb-100-anti-cancer-compound-to-taipei-medical-university-040116-4766625/ 2016-01-04T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/yisheng-unveils-positive-results-of-phase-i-clinical-trial-of-pika-rabies-vaccine-040116-4766642/ 2016-01-04T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-pfizer-and-syndax-to-investigate-avelumab-and-entinostat-combination-for-ovarian-cancer-050116-4767380/ 2016-01-05T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/baxalta-symphogen-form-immuno-oncology-collaboration-050116-4767664/ 2016-01-05T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-to-gilead-sciences-hepatitis-c-combination-drug-050116-4767725/ 2016-01-05T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merus-gustave-roussy-partner-to-develop-bispecific-antibodies-for-therapeutic-immuno-oncology-applications-050116-4767741/ 2016-01-05T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/european-medicines-agency-validates-sunesis-maa-for-vosaroxin-in-aml-050116-4767750/ 2016-01-05T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/matinas-biopharma-files-ind-with-fda-for-lead-antibacterial-development-candidate-mat2501-050116-4767765/ 2016-01-05T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/circulating-tumor-cells-linked-with-treatment-resistance-and-response-in-prostate-cancer-patients-050116-4767788/ 2016-01-05T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/akebia-starts-phase-3-pro2tect-program-4767802/ 2016-01-05T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-ionis-htt-rx-to-treat-huntingtons-disease-060116-4768358/ 2016-01-06T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-stops-phase-2-study-of-simtuzumab-for-treatment-of-idiopathic-pulmonary-fibrosis-060116-4768420/ 2016-01-06T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-ends-deal-with-mannkind-for-afrezza-inhaled-insulin-060116-4768926/ 2016-01-06T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/conatus-achieves-positive-results-with-emricasan-in-initial-stage-of-trial-060116-4768941/ 2016-01-06T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/actelion-announces-us-commercial-availability-of-uptravi-selexipag-060116-4768952/ 2016-01-06T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/sillajen-starts-phase-3-open-label-study-of-pexa-vec-in-advanced-liver-cancer-060116-4768974/ 2016-01-06T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/ani-pharmaceuticals-acquires-two-ndas-from-merck-for-75m-060116-4768983/ 2016-01-06T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/emberas-emb-001-drug-meets-primary-endpoints-to-treat-addictions-070116-4769734/ 2016-01-07T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/recro-pharmas-iv-meloxicam-painkiller-succeeds-in-phase-ii-clinical-trial-070116-4770258/ 2016-01-07T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-selects-first-clinical-candidate-in-discovery-collaboration-with-immunocore-070116-4770303/ 2016-01-07T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/ose-pharma-starts-phase-3-trial-of-tedopi-in-non-small-cell-lung-cancer-070116-4770321/ 2016-01-07T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/x-chem-partners-with-sanofi-to-discover-lead-molecules-against-various-targets-070116-4770340/ 2016-01-07T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/vernalis-selects-corvus-pharmaceuticals-as-global-licensee-for-adenosine-antagonist-program-070116-4770355/ 2016-01-07T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/peregrine-nccn-partner-to-evaluate-novel-cancer-treatment-combinations-with-bavituximab-070116-4770373/ 2016-01-07T05:16:00+00:00